N-CSR 1 d943592dncsr.htm ISHARES U.S. ETF TRUST iShares U.S. ETF Trust

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM N-CSR

 

 

CERTIFIED SHAREHOLDER REPORT

OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-22649

 

 

iShares U.S. ETF Trust

(Exact name of registrant as specified in charter)

 

 

c/o: State Street Bank and Trust Company

100 Summer Street, 4th Floor, Boston, MA 02110

(Address of principal executive offices) (Zip code)

 

 

The Corporation Trust Company

1209 Orange Street, Wilmington, DE 19801

(Name and address of agent for service)

 

 

Registrant’s telephone number, including area code: (415) 670-2000

Date of fiscal year end: July 31, 2020

Date of reporting period: July 31, 2020

 

 

 


Item 1.    Reports to Stockholders.

Copies of the annual reports transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 are attached.

 


 

LOGO   JULY 31, 2020

 

   2020 Annual Report

 

iShares U.S. ETF Trust

 

·  

iShares Evolved U.S. Consumer Staples ETF  |  IECS  |  Cboe BZX

·  

iShares Evolved U.S. Discretionary Spending ETF  |  IEDI  |  Cboe BZX

·  

iShares Evolved U.S. Financials ETF  |  IEFN  |  Cboe BZX

·  

iShares Evolved U.S. Healthcare Staples ETF  |  IEHS  |  Cboe BZX

·  

iShares Evolved U.S. Innovative Healthcare ETF  |  IEIH  |  Cboe BZX

·  

iShares Evolved U.S. Media and Entertainment ETF  |  IEME  |  Cboe BZX

·  

iShares Evolved U.S. Technology ETF  |  IETC  |  Cboe BZX

 

 

Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of each Fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from your financial intermediary, such as a broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.

You may elect to receive all future reports in paper free of charge. If you hold accounts through a financial intermediary, you can follow the instructions included with this disclosure, if applicable, or contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. Please note that not all financial intermediaries may offer this service. Your election to receive reports in paper will apply to all funds held with your financial intermediary.

If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive electronic delivery of shareholder reports and other communications by contacting your financial intermediary. Please note that not all financial intermediaries may offer this service.


The Markets in Review

Dear Shareholder,

The last 12 months have been a time of sudden change in global financial markets, as a long period of growth and positive returns was interrupted in early 2020 by the emergence and spread of the coronavirus. For the first half of the reporting period, U.S. equities and bonds both delivered impressive returns, despite fears and doubts about the economy that were ultimately laid to rest with unprecedented monetary stimulus and a sluggish yet resolute performance from the U.S. economy. But as the threat from the coronavirus (or “COVID-19”) became more apparent throughout February and March 2020, countries around the world took economically disruptive countermeasures, causing a global recession and a sharp fall in equity prices. While markets have since recovered most of these losses as countries around the world adapt to life with the virus, lingering uncertainty about the depth and duration of the pandemic and an uptick in global infection rates tempered optimism late in the reporting period.

Returns for most securities were robust for the first half of the reporting period, as investors began to realize that the U.S. economy was maintaining the modest yet steady growth that had characterized this economic cycle. However, once stay-at-home orders and closures of non-essential businesses became widespread, many workers were laid off and unemployment claims spiked. The subsequent rapid decline in equity prices was followed by a slow recovery, and some economic indicators began to improve. U.S. large-capitalization stocks, which are often considered more resilient than smaller companies during market turbulence, advanced significantly. International equities from developed economies ended the 12-month reporting period with negative performance, while emerging market stocks posted a positive return.

The performance of different types of fixed-income securities diverged substantially due to a reduced investor appetite for risk. Treasuries benefited from the risk-off environment, and posted healthy returns, as the 10-year U.S. Treasury yield (which is inversely related to bond prices) fell to an all-time low. Investment-grade corporate bonds also delivered solid returns, while high-yield corporate returns were more modest due to credit concerns.

The U.S. Federal Reserve (the “Fed”) reduced interest rates three times in 2019, to support slowing economic growth. After the coronavirus outbreak, the Fed instituted two emergency rate cuts, pushing short-term interest rates close to zero. To stabilize credit markets, the Fed also implemented a new bond-buying program, as did several other central banks around the world, including the European Central Bank and the Bank of Japan.

Looking ahead, while coronavirus-related disruptions have clearly hindered worldwide economic growth, we believe that the global expansion is likely to continue once the outbreak subsides. Several risks remain, however, including a potential resurgence of the coronavirus amid loosened restrictions, policy fatigue among governments already deep into deficit spending, and structural damage to the financial system from lengthy economic interruptions.

Overall, we favor a moderately positive stance toward risk, and in particular toward credit given the extraordinary central bank measures taken in recent months. This support extends beyond investment-grade corporates and into high-yield, leading to attractive opportunities throughout the credit market. We believe that both U.S. Treasuries and sustainable investments can help provide portfolio resilience, and the disruption created by the coronavirus appears to be accelerating the shift toward sustainable investments. We remain neutral on equities overall while favoring European stocks, which are poised for cyclical upside as re-openings continue.

In this environment, our view is that investors need to think globally, extend their scope across a broad array of asset classes, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

BlackRock, Inc.

LOGO

Rob Kapito

BlackRock, Inc.

 

Total Returns as of July 31, 2020
     6-Month    12-Month

U.S. large cap equities
(S&P 500® Index)

  2.42%   11.96%

U.S. small cap equities
(Russell 2000® Index)

  (7.61)   (4.59)

International equities
(MSCI Europe, Australasia, Far East Index)

  (7.34)   (1.67)

Emerging market equities
(MSCI Emerging Markets Index)

  3.08   6.55

3-month Treasury bills
(ICE BofA 3-Month U.S. Treasury Bill Index)

  0.48   1.46

U.S. Treasury securities
(ICE BofA 10-Year U.S. Treasury Index)

  9.92   15.55

U.S. investment grade bonds
(Bloomberg Barclays U.S. Aggregate Bond Index)

  5.69   10.12

Tax-exempt municipal bonds
(S&P Municipal Bond Index)

  1.75   4.89

U.S. high yield bonds
(Bloomberg Barclays U.S. Corporate High Yield 2% Issuer Capped Index)

  0.62   4.07
Past performance is no guarantee of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

 

2  

THIS PAGE IS NOT PART OF YOUR FUND REPORT


Table of Contents

 

      Page  

The Markets in Review

     2  

Market Overview

     4  

Fund Summary

     5  

About Fund Performance

     19  

Shareholder Expenses

     19  

Schedules of Investments

     20  

Financial Statements:

  

Statements of Assets and Liabilities

     44  

Statements of Operations

     46  

Statements of Changes in Net Assets

     48  

Financial Highlights

     52  

Notes to Financial Statements

     59  

Report of Independent Registered Public Accounting Firm

     67  

Important Tax Information (Unaudited)

     68  

Board Review and Approval of Investment Advisory Contract

     69  

Supplemental Information

     71  

Trustee and Officer Information

     74  

General Information

     76  

Glossary of Terms Used in this Report

     77  

 

 

  3


Market Overview

 

iShares U.S. ETF Trust

Domestic Market Overview

The coronavirus pandemic and the resulting economic disruptions led to high volatility in the 12 months ended July 31, 2020 (“reporting period”), as investors tried to assess the economic impact. A steep decline in stocks, beginning in late February 2020, was followed by a steady recovery, leading to a return of 10.93% for the Russell 3000® Index, a broad measure of U.S. equity market performance. Large capitalization stocks performed particularly well, with the S&P 500® Index returning 11.96% for the reporting period.

The first half of the reporting period was characterized by a steadily improving economy and a strong job market. The U.S. set a record for the most consecutive months of both economic growth and job growth, as the unemployment rate declined to its lowest level in 50 years. Equity markets were further buoyed by a tentative trade agreement between the U.S. and China in December 2019.

However, the economic expansion was abruptly interrupted in February 2020, as the coronavirus began to spread globally, and the U.S. economy declined into a deep recession. As the U.S. and other countries began to limit travel and economic activity, in an attempt to reduce the transmission of the coronavirus, equity markets sank, and stocks in the U.S. posted their steepest declines since the 2008 financial crisis.

Following the issuance of stay-at-home orders and other restrictions on public gatherings and nonessential work, whole portions of the U.S. economy shut down. Businesses associated with travel and leisure were particularly affected, as air traffic declined, and conferences and events were postponed. Unemployment increased dramatically as record jobless claims brought the unemployment rate up to 14.7% in April 2020, the highest rate since the Great Depression.

In response to the crisis, the federal government enacted several rounds of stimulus spending, including the U.S. $1.8 trillion CARES Act. The stimulus was designed to stabilize affected industries, make loans to small businesses, and provide direct cash payments to individuals. In April 2020, an additional U.S. $484 billion in aid for small businesses and hospitals was added, and in July 2020 congress began negotiating another round of stimulus as the impact of the coronavirus continued to disrupt the economy.

The U.S. Federal Reserve Bank (“Fed”), which had already lowered interest rates three times in 2019 to boost a slowing economy, also responded to the crisis with unprecedented monetary policy measures. In March 2020, the Fed enacted two emergency interest rate reductions to restore confidence in markets, bringing short-term interest rates down to a range of 0.00% – 0.25%. The Fed further acted to stabilize credit markets by purchasing U.S. Treasuries, corporate and municipal bonds, and securities backed by mortgages and auto loans.

The combination of support from government stimulus, Fed intervention, and optimism surrounding development of a coronavirus vaccine led to a significant recovery in stock prices beginning in late March 2020. Despite a substantial economic contraction of 9.5% in the second quarter of 2020, a record setting quarterly decline, investors were encouraged by signs of improving economic conditions in May and June 2020 as unemployment declined and consumer spending increased. While corporate earnings were significantly down overall in the second quarter of 2020, investors anticipated that further economic progress and new developments in treating the virus would lead to higher future earnings growth. By the end of the reporting period, many stock prices were near their pre-coronavirus highs.

 

 

4  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Consumer Staples ETF

 

Investment Objective

The iShares Evolved U.S. Consumer Staples ETF (the “Fund”) seeks to provide access to U.S. companies with consumer staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    4.56      8.86       4.56      22.24

Fund Market

    4.45        8.84         4.45        22.19  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return         
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
    

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 986.50        $ 0.94             $ 1,000.00        $ 1,023.90        $ 0.96        0.19

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  5


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Consumer Staples ETF

 

Portfolio Management Commentary

U.S. consumer staples stocks advanced during the reporting period, as companies benefited from continued demand and low exposure to international supply chains that were disrupted during the coronavirus pandemic. Consumers shifted away from in-person restaurant visits and toward eating at home in response to the coronavirus, strengthening some consumer staples companies while weakening others. Lower interest rates also increased the appeal of consumer staples stocks, which often pay substantial dividends.

Demand rose for some consumer staples used in the home during the pandemic. Food companies, which includes General Mills and other makers of consumer food products, contributed substantially to the Fund’s return. Demand for packaged foods like Cheerios increased considerably during the coronavirus pandemic, as consumers built reserves in anticipation of further disruptions. Makers of household products, such as Procter & Gamble, also benefited from changing purchasing patterns during the pandemic. Coronavirus-related concerns drove demand for household cleaning supplies, including Mr. Clean, as consumers became more conscious about keeping surfaces disinfected. However, the shift of work from offices to homes also transferred demand for commercial bathroom tissue to consumer bathroom tissue brands, such as Charmin. Beverage and soft drink company stocks, including PepsiCo and Monster Beverage, advanced during the reporting period. Drink makers created new outlets for direct online sales, even as the closing of restaurants reduced beverage revenue.

On the downside, restaurants detracted from the Fund’s return. Many restaurant stocks, such as Starbucks, declined significantly due to coronavirus-related restrictions. Earnings decreased considerably amid substantially lower same-store sales, as numerous restaurant locations closed temporarily or limited operations to drive-through and takeout.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer staples companies with similar businesses that have traditionally been categorized in other sectors. For instance, the Fund held positions in Chipotle Mexican Grill, Yum China Holdings, and Wingstop, which are generally classified as companies in the consumer discretionary sector. These particular stocks contributed to performance, partly due to effective takeout offerings, despite the overall decline in restaurant visits during the pandemic.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Beverages

    29.0

Food

    25.4  

Retail

    11.8  

Cosmetics & Personal Care

    11.3  

Agriculture

    10.8  

Household Products & Wares

    3.0  

Packaging & Containers

    2.8  

Pharmaceuticals

    2.5  

Real Estate Investment Trusts

    1.4  

Chemicals

    1.1  

Other (each representing less than 1%)

    0.9  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

Coca-Cola Co. (The)

    11.0

PepsiCo Inc.

    10.7  

Procter & Gamble Co. (The)

    8.6  

Mondelez International Inc., Class A

    4.6  

Philip Morris International Inc.

    4.6  

McDonald’s Corp.

    4.4  

Altria Group Inc.

    4.1  

Starbucks Corp.

    3.8  

General Mills Inc.

    3.6  

Monster Beverage Corp.

    2.8  
 

 

  (a) 

Excludes money market funds.

 

 

 

6  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Discretionary Spending ETF

 

Investment Objective

The iShares Evolved U.S. Discretionary Spending ETF (the “Fund”) seeks to provide access to U.S. companies with discretionary spending exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    18.11      16.15       18.11      42.47

Fund Market

    18.04        16.13         18.04        42.42  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,108.80        $ 0.94             $ 1,000.00        $ 1,024.00        $ 0.91          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  7


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Discretionary Spending ETF

 

Portfolio Management Commentary

Stocks related to U.S. discretionary spending advanced strongly for the reporting period, as coronavirus-related restrictions reinforced the shift toward online buying across industries. However, the mix of goods consumers purchased online changed considerably due to the recession and the pandemic.

E-commerce retailers, such as Amazon.com, advanced significantly during the reporting period. The temporary closure of many brick-and-mortar retailers and shortages of some goods accelerated the preexisting shift toward e-commerce, with consumers increasingly buying essential goods online. The Amazon Marketplace, which allows other companies and individuals to sell goods on Amazon.com for a fee, was a driver of growth, as small businesses tapped into e-commerce during the pandemic. Amazon’s large customer base and wide selection of products made it the default choice for many new online buyers of items like bathroom tissue, but traditional retailers with a strong e-commerce platform, such as Target Corporation, also increased their online sales.

The shift toward increased use of technology as more people stayed at home benefited consumer technology companies as well, most notably Apple. Demand for wearable technology like the Apple Watch, which has many health applications, continued to expand. Apple’s revenue from services, such as the App Store and Apple Pay, also rose as consumers increased in-app purchases and stores expanded contactless payment support during the pandemic.

As consumers stayed home, they also spent money on home goods. Home improvement retail stocks, such as Home Depot and Lowe’s Companies, advanced meaningfully amid increased consumer demand for materials for do-it-yourself projects. Superstores like Walmart benefited from higher demand for essential goods, as well as home improvement supplies.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several discretionary spending companies with similar businesses that have traditionally been categorized in other sectors. For instance, the Fund held positions in Apple, PayPal Holdings, and Square, which are generally classified as companies in the information technology sector. These stocks posted substantial gains as customers turned to contactless payments to avoid exposure to the coronavirus.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Retail

    50.1

Internet

    23.8  

Computers

    6.0  

Apparel

    5.8  

Cosmetics & Personal Care

    3.9  

Commercial Services

    2.0  

Lodging

    1.8  

Food

    1.5  

Distribution & Wholesale

    1.0  

Other (each representing less than 1%)

    4.1  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

Amazon.com Inc.

    20.0

Home Depot Inc. (The)

    8.2  

Walmart Inc.

    6.1  

Apple Inc.

    6.0  

Costco Wholesale Corp.

    4.8  

Nike Inc., Class B

    3.5  

Lowe’s Companies Inc.

    3.1  

McDonald’s Corp.

    3.1  

Procter & Gamble Co. (The)

    2.9  

TJX Companies Inc. (The)

    2.4  
 

 

  (a) 

Excludes money market funds.

 

 

 

8  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Financials ETF

 

Investment Objective

The iShares Evolved U.S. Financials ETF (the “Fund”) seeks to provide access to U.S. companies with financials exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    (15.10 )%       (5.83 )%        (15.10 )%       (13.23 )% 

Fund Market

    (15.06      (5.81       (15.06      (13.19

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 810.20        $ 0.86             $ 1,000.00        $ 1,023.90        $ 0.96          0.19

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  9


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Financials ETF

 

Portfolio Management Commentary

Financials stocks declined sharply for the reporting period. Although financials stocks advanced steadily in 2019 amid solid economic growth and a favorable regulatory environment, the economic disruption precipitated by the coronavirus pandemic led to sharp declines among financials stocks. The Fed’s stimulus, which reduced interest rates to historically low levels, further pressured the profitability of many financials companies.

Banks detracted the most from the Fund’s performance, as lower asset prices led to reduced management fees, and declining consumer spending prompted concerns that credit demand would weaken. For example, Wells Fargo, a large diversified bank, declined significantly amid sharply higher loan loss provisions in anticipation of more defaults. The bank’s dividend reduction and lingering effects of earlier scandals also contributed to declines. Similarly, Citigroup declined due to an increase in bad loans and expectations of further defaults amid higher unemployment and rising bankruptcies. Smaller regional banks like Truist Financial also detracted amid expectations of higher loan defaults.

Insurance companies were also notable detractors, led by life insurance companies, such as Prudential Financial, which declined amid expectations of policy losses from pandemic-related deaths and lower income as bond yields declined. An increase in coronavirus-related workers compensation and travel claims weighed on large insurance companies operating in multiple segments, such as AIG. Revenues also declined due to lower premiums and investment losses. Consumer finance companies weakened as consumer credit card spending declined amid the pandemic. For example, lower entertainment and travel spending, both of which declined sharply amid pandemic-related travel restrictions, weighed heavily on American Express.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several financials companies with similar businesses that have traditionally been categorized in other sectors. For example, the process identified several managed healthcare companies, including UnitedHealth, which benefited amid lower payments for medical care during the pandemic. Mastercard, an electronic payment processor in the software and services industry, benefited from expectations of continued growth in digital payments, especially in emerging markets.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Banks

    39.9

Insurance

    26.5  

Diversified Financial Services

    14.1  

Commercial Services

    6.0  

Health Care — Services

    3.9  

Software

    3.6  

Savings & Loans

    1.2  

Other (each representing less than 1%)

    4.8  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

Bank of America Corp.

    4.5

JPMorgan Chase & Co.

    4.3  

Wells Fargo & Co.

    4.1  

Citigroup Inc.

    3.4  

Berkshire Hathaway Inc., Class B

    2.8  

Goldman Sachs Group Inc. (The)

    2.5  

Truist Financial Corp.

    2.3  

U.S. Bancorp.

    2.3  

Progressive Corp. (The)

    2.2  

Morgan Stanley

    2.2  
 

 

  (a) 

Excludes money market funds.

 

 

 

10  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Healthcare Staples ETF

 

Investment Objective

The iShares Evolved U.S. Healthcare Staples ETF (the “Fund”) seeks to provide access to U.S. companies with healthcare staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    15.04      14.81       15.04      38.61

Fund Market

    15.07        14.82         15.07        38.65  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,069.70        $ 0.93             $ 1,000.00        $ 1,024.00        $ 0.91          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  11


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Healthcare Staples ETF

 

Portfolio Management Commentary

U.S. healthcare staples stocks advanced strongly during the reporting period, rebounding after a sharp coronavirus-related market decline to end the reporting period with significant gains amid investor optimism about coronavirus treatments and vaccines and higher demand for testing and laboratory equipment. Healthcare equipment stocks contributed the most to the Fund’s return, bolstered by medical device innovations to treat chronic diseases. For example, Abbott Laboratories advanced due to strong sales and new devices for continuous blood-glucose monitoring that can work together with an insulin pump for managing diabetes. Strong demand for the company’s COVID-19 infection and antibody tests, which offered relatively fast delivery of test results, also drove gains. Similarly, the need for remote consultations with diabetic patients, who generally experience worse outcomes from contracting the coronavirus, drove strong sales of DexCom’s smart blood sugar monitor, which transmits the patient’s data to physicians.

Danaher Corporation benefited from strong sales of its rapid COVID-19 test, which eliminates the lag time of laboratory analysis, enabling higher testing levels and quicker responses to outbreaks. Emergency U.S. Food and Drug Administration approval of the company’s test that identifies coronavirus antibodies also supported Danaher’s gains.

Managed healthcare companies, such as UnitedHealth Group, posted strong earnings growth as consumers delayed medical care during the pandemic, which also postponed treatment payments. The life sciences tools and services industry was a modest contributor, largely due to Thermo Fisher Scientific, as lower demand for some scientific instruments amid coronavirus disruptions was more than offset by rising sales of equipment used for developing coronavirus vaccines and treatments.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activities. More specifically, the evolved investment process identified several companies with healthcare-related businesses in the healthcare real estate investment trusts industry. Senior care facilities like Ventas and Welltower generally declined due to lower occupancy rates and higher health and safety expenses after the coronavirus outbreak, which detracted from the Fund’s performance for the reporting period. However, Medical Properties Trust, a company that leases properties to hospitals, was more resilient and contributed marginally to performance, as occupancy rates remained high during the pandemic.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Health Care — Products

    47.6

Health Care — Services

    25.7  

Pharmaceuticals

    17.2  

Biotechnology

    4.1  

Real Estate Investment Trusts

    1.3  

Electronics

    1.3  

Other (each representing less than 1%)

    2.8  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

UnitedHealth Group Inc.

    11.0

Abbott Laboratories

    8.5  

Medtronic PLC

    6.0  

Johnson & Johnson

    5.0  

Thermo Fisher Scientific Inc.

    4.4  

Danaher Corp.

    3.9  

Intuitive Surgical Inc.

    3.6  

Becton Dickinson and Co.

    3.3  

Stryker Corp.

    3.0  

CVS Health Corp.

    2.6  
 

 

  (a) 

Excludes money market funds.

 

 

 

12  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Innovative Healthcare ETF

 

Investment Objective

The iShares Evolved U.S. Innovative Healthcare ETF (the “Fund”) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    25.31      10.68       25.31      27.11

Fund Market

    25.26        10.68         25.26        27.11  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,115.10        $ 0.95             $ 1,000.00        $ 1,024.00        $ 0.91          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  13


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Innovative Healthcare ETF

 

Portfolio Management Commentary

U.S. innovative healthcare stocks advanced strongly despite disruption created by the coronavirus pandemic. During the first half of the reporting period, the Fund advanced steadily amid ongoing innovations in gene-based therapies, a favorable regulatory environment, clinical successes, and merger and acquisition activity. Following the emergence of the coronavirus, innovative healthcare stocks initially declined along with broad global markets but rebounded to post strong gains for the reporting period.

Biotechnology companies focusing on treatment and vaccines for the coronavirus were principal drivers of the Fund’s return. For example, Regeneron advanced sharply after announcing its intent to make an antibody therapy for treating and preventing the coronavirus. The drug uses genetic material to generate antibodies that provoke an immune response by blocking the spiky proteins that infect human cells. AbbVie’s announcement of a plan to develop a coronavirus treatment, along with continued diversification via acquisitions and development partnerships, bolstered the industry.

Biotechnology companies producing treatments for chronic conditions that increase the likelihood of severe coronavirus illness also performed well. Companies such as Vertex Pharmaceuticals raised earnings forecasts amid strong sales of its treatment for cystic fibrosis, a genetic lung disease.

Pharmaceuticals companies contributed modestly, driven by optimism about using existing medications for treating coronavirus complications. For example, Eli Lilly began a study to look at the use of its rheumatoid arthritis drug to reduce inflammation caused by COVID-19. Industry consolidation, such as Bristol Myers Squibb’s acquisition of Celgene, which resulted in a stronger pipeline, was also beneficial.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. As of the end of the reporting period, the Fund’s portfolio consisted primarily of biotechnology and pharmaceuticals companies that emphasize innovation, but also included companies in diverse industries such as medical equipment. For example, DexCom, which makes smart blood-glucose monitors, posted strong sales during the pandemic, as physicians sought tools for remote consultations with diabetic patients, who are at higher risk for complications from the coronavirus.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Pharmaceuticals

    48.0

Biotechnology

    47.1  

Health Care — Products

    3.3  

Health Care — Services

    1.4  

Other (each representing less than 1%)

    0.2  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

Johnson & Johnson

    8.8

Merck & Co. Inc.

    6.2  

Pfizer Inc.

    5.5  

AbbVie Inc.

    5.0  

Amgen Inc.

    4.9  

Vertex Pharmaceuticals Inc.

    4.7  

Eli Lilly & Co.

    4.7  

Regeneron Pharmaceuticals Inc.

    4.7  

Bristol-Myers Squibb Co.

    4.5  

Gilead Sciences Inc.

    4.1  
 

 

  (a) 

Excludes money market funds.

 

 

 

14  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Media and Entertainment ETF

 

Investment Objective

The iShares Evolved U.S. Media and Entertainment ETF (the “Fund”) seeks to provide access to U.S. companies with media and entertainment exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    (2.33 )%       4.90       (2.33 )%       11.98

Fund Market

    (2.33      4.92         (2.33      12.02  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 982.20        $ 0.94             $ 1,000.00        $ 1,023.90        $ 0.96          0.19

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  15


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Media and Entertainment ETF

 

Portfolio Management Commentary

U.S. media and entertainment stocks declined modestly for the reporting period, as the coronavirus pandemic changed the landscape of the industry. Pandemic-related restrictions forced entertainment venues to close, sharply reducing media companies’ revenue. Partially offsetting these losses, home entertainment sales rose as consumers stayed home.

Broadcasting stocks drove detraction from the Fund’s performance amid pandemic-related disruptions, especially canceled entertainment productions. The mass media company ViacomCBS declined as new movie productions and releases were postponed and movie theaters closed, accelerating pre-existing weakness in movie theatre admissions. The canceled NCAA basketball tournament and consumers dropping their cable television subscriptions also weighed on revenue. Fox Corporation, whose revenue is dependent on local broadcast stations, also detracted amid declining advertising revenues.

Entertainment conglomerate Walt Disney was a significant detractor from the Fund’s return. Closed theme parks and resorts, cruise line suspensions, and disrupted studio operations drove sharply lower revenue. Additionally, delayed major league sports seasons constrained Disney’s ESPN revenues. However, these losses were partially offset by growth in the company’s new streaming service, Disney Plus.

On the upside, home digital entertainment contributed to the Fund’s performance due to an increase in online games played during pandemic-related restrictions. Activision Blizzard advanced amid strong demand for its newly released game, Warzone, Call of Duty. Video game maker ElectronicArts also advanced due to the popularity of several of its franchises, including Star Wars, and strong live-services revenue.

Internet service providers were also significant contributors, as consumers increased internet use during stay-at-home restrictions. Charter Communications, for example, advanced due to increased broadband internet subscriptions.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several media and entertainment companies with similar businesses that have traditionally been categorized in other sectors. For example, Hasbro, a toy and game manufacturer in the consumer discretionary sector, which detracted from the Fund’s performance, expanded its presence into digital media, adding properties such as Peppa Pig to its portfolio. Hasbro’s stock declined amid investor concerns that disruptions to Chinese manufacturing would affect supply chains for its products.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Media

    57.6

Internet

    16.6  

Software

    13.7  

Entertainment

    3.8  

Toys, Games & Hobbies

    2.7  

Telecommunications

    1.3  

Commercial Services

    1.2  

Retail

    1.1  

Other (each representing less than 1%)

    2.0  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

ViacomCBS Inc., Class B

    5.7

Comcast Corp., Class A

    5.2  

Charter Communications Inc., Class A

    5.1  

Walt Disney Co. (The)

    4.8  

Electronic Arts Inc.

    4.8  

Activision Blizzard Inc.

    4.6  

Netflix Inc.

    4.5  

Liberty Broadband Corp., Class C

    4.2  

Roku Inc.

    3.5  

Fox Corp., Class A

    3.4  
 

 

  (a) 

Excludes money market funds.

 

 

 

16  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2020    iShares® Evolved U.S. Technology ETF

 

Investment Objective

The iShares Evolved U.S. Technology ETF (the “Fund”) seeks to provide access to U.S. companies with technology exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

      Average Annual Total Returns               Cumulative Total Returns    
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    37.15      24.41       37.15      67.59

Fund Market

    37.10        24.46         37.10        67.75  

S&P Total Market IndexTM

    10.80        9.47               10.80        23.79  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Certain sectors and markets performed exceptionally well based on market conditions during the one-year period. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such exceptional returns will be repeated.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 19 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/20)
 
 
 
      

Ending
Account Value
(07/31/20)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,000.00        $ 0.90             $ 1,000.00        $ 1,024.00        $ 0.91          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (182 days) and divided by the number of days in the year (366 days). See “Shareholder Expenses” on page 19 for more information.

 

 

 

FUND SUMMARY

  17


Fund Summary  as of July 31, 2020 (continued)    iShares® Evolved U.S. Technology ETF

 

Portfolio Management Commentary

U.S. technology stocks advanced robustly during the reporting period, as the coronavirus pandemic accelerated technological trends. Software sales and subscriptions rose, as companies adopted solutions for remote work and online shopping increased during stay-at-home restrictions. Telecommuting drove higher personal computer sales and strong demand growth for chips used in 5G wireless technology and cloud data centers.

The software industry contributed the most to the Fund’s return, as companies adopted new computing technologies for remote work. Microsoft drove contribution among software stocks, advancing due to sharply rising demand for products and services that supported remote computing amid the rise in telecommuting due to stay-at-home directives. Sales of Microsoft’s intelligent cloud computing platform, Azure, and video conferencing solutions rose sharply. Revenue from the company’s Xbox console also climbed higher due to increased video game sales and subscriptions. Hardware technology companies benefited performance as well. Apple gained amid strong sales growth of iPhones, iPads, and Mac computers, as people increased purchases of consumer electronics that help them remain connected to others while practicing social distancing. More time spent at home fueled an increase in app purchases by consumers, which further drove the company’s revenue growth.

Semiconductors stocks were also notable contributors, supported by escalating demand for chips used for 5G wireless technology, artificial intelligence-driven data centers, and personal computers. Nvidia, for example, benefited from consumers upgrading their computing equipment and video game consoles during stay-at-home orders.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several technology companies with similar businesses that have traditionally been categorized in other sectors. For example, the Fund held a position in Amazon.com, traditionally classified as a retail stock. The company benefited from increased online shopping as consumers avoided physical stores during stay-at-home restrictions. Amazon also gained amid growth in demand for its cloud services and higher Prime membership subscriptions, particularly for grocery delivery. The Fund also held a position in Google’s parent company Alphabet, traditionally categorized as a communications services stock, which advanced amid growth in cloud computing.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector    
Percent of
Total Investments
 
(a) 

Software

    32.6

Internet

    26.4  

Computers

    16.5  

Semiconductors

    9.2  

Diversified Financial Services

    5.1  

Commercial Services

    4.8  

Telecommunications

    2.4  

Other (each representing less than 1%)

    3.0  

TEN LARGEST HOLDINGS

 

Security    
Percent of
Total Investments
 
(a) 

Microsoft Corp.

    16.6

Apple Inc.

    12.3  

Amazon.com Inc.

    8.6  

Facebook Inc., Class A

    5.5  

Alphabet Inc., Class A

    4.1  

Alphabet Inc., Class C

    3.9  

NVIDIA Corp.

    2.6  

Visa Inc., Class A

    2.4  

Adobe Inc.

    2.1  

Cisco Systems Inc.

    1.9  
 

 

  (a)

Excludes money market funds.

 

 

 

18  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


About Fund Performance

 

Past performance is no guarantee of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of the fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at iShares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.

Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. The price used to calculate market return (“Market Price”) is determined by using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.

An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.

Shareholder Expenses

As a shareholder of your Fund, you incur two types of costs: (1) transaction costs, including brokerage commissions on purchases and sales of fund shares and (2) ongoing costs, including management fees and other fund expenses. The expense example, which is based on an investment of $1,000 invested at the beginning of the period (or from the commencement of operations if less than 6 months) and held through the end of the period, is intended to help you understand your ongoing costs (in dollars and cents) of investing in your Fund and to compare these costs with the ongoing costs of investing in other funds.

Actual Expenses — The table provides information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. To estimate the expenses that you paid on your account over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number under the heading entitled “Expenses Paid During the Period.”

Hypothetical Example for Comparison Purposes — The table also provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

 

ABOUT FUND PERFORMANCE / SHAREHOLDER EXPENSES

  19


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   
Advertising — 0.0%            

Omnicom Group Inc.

    60     $ 3,224  
   

 

 

 
Agriculture — 10.7%            

Altria Group Inc.

    9,737       400,678  

Archer-Daniels-Midland Co.

    3,372       144,423  

Bunge Ltd.

    750       32,580  

Darling Ingredients Inc.(a)

    609       17,009  

Fresh Del Monte Produce Inc.

    118       2,664  

Philip Morris International Inc.

    5,813       446,497  

Universal Corp./VA

    147       6,197  

Vector Group Ltd.

    263       2,320  
   

 

 

 
      1,052,368  
Beverages — 28.8%            

Boston Beer Co. Inc. (The), Class A, NVS(a)

    42       34,038  

Brown-Forman Corp., Class A

    261       16,506  

Brown-Forman Corp., Class B, NVS

    1,839       127,516  

Coca-Cola Co. (The)

    22,739       1,074,190  

Coca-Cola Consolidated Inc.

    36       8,264  

Constellation Brands Inc., Class A

    726       129,373  

Keurig Dr Pepper Inc.

    2,788       85,285  

MGP Ingredients Inc.

    77       2,793  

Molson Coors Beverage Co., Class B

    1,050       39,396  

Monster Beverage Corp.(a)

    3,447       270,521  

National Beverage Corp.(a)

    105       6,736  

PepsiCo Inc.

    7,580       1,043,463  
   

 

 

 
      2,838,081  
Chemicals — 1.0%            

Balchem Corp.

    114       11,430  

Ecolab Inc.

    116       21,701  

International Flavors & Fragrances Inc.

    489       61,590  

Sensient Technologies Corp.

    168       8,771  
   

 

 

 
      103,492  
Commercial Services — 0.1%            

Medifast Inc.

    41       6,853  

WW International Inc.(a)(b)

    126       3,248  
   

 

 

 
      10,101  
Computers — 0.0%            

ExlService Holdings Inc.(a)

    69       4,420  
   

 

 

 
Cosmetics & Personal Care — 11.2%            

Colgate-Palmolive Co.

    3,277       252,984  

Coty Inc., Class A

    587       2,178  

Edgewell Personal Care Co.(a)

    150       4,483  

Estee Lauder Companies Inc. (The), Class A

    1       198  

Procter & Gamble Co. (The)

    6,424       842,315  
   

 

 

 
      1,102,158  
Distribution & Wholesale — 0.0%            

Core-Mark Holding Co. Inc.

    161       4,270  
   

 

 

 
Diversified Financial Services — 0.0%            

CME Group Inc.

    1       166  

Jefferies Financial Group Inc.

    2       33  
   

 

 

 
      199  
Electric — 0.0%            

Entergy Corp.

    31       3,259  
   

 

 

 
Electrical Components & Equipment — 0.1%            

Energizer Holdings Inc.

    168       8,422  
   

 

 

 
Security   Shares      Value  
Food — 25.2%             

B&G Foods Inc.

    539      $ 15,582  

BellRing Brands Inc., Class A(a)

    194        3,855  

Beyond Meat Inc.(a)

    272        34,245  

Calavo Growers Inc.

    77        4,448  

Cal-Maine Foods Inc.(a)

    140        6,152  

Campbell Soup Co.

    1,557        77,181  

Conagra Brands Inc.

    3,800        142,310  

Flowers Foods Inc.

    833        18,951  

General Mills Inc.

    5,577        352,857  

Hain Celestial Group Inc. (The)(a)(b)

    728        24,737  

Hershey Co. (The)

    1,280        186,125  

Hormel Foods Corp.

    1,707        86,818  

Hostess Brands Inc.(a)

    455        5,769  

Ingredion Inc.

    399        34,514  

J&J Snack Foods Corp.

    91        11,205  

JM Smucker Co. (The)

    929        101,586  

John B Sanfilippo & Son Inc.

    63        5,555  

Kellogg Co.

    2,308        159,229  

Kraft Heinz Co. (The)

    4,756        163,511  

Lamb Weston Holdings Inc.

    938        56,355  

Lancaster Colony Corp.

    119        18,872  

McCormick & Co. Inc./MD, NVS(b)

    697        135,845  

Mondelez International Inc., Class A

    8,054        446,916  

Performance Food Group Co.(a)

    427        11,965  

Pilgrim’s Pride Corp.(a)

    210        3,224  

Post Holdings Inc.(a)

    574        50,937  

Sanderson Farms Inc.

    84        9,366  

Seaboard Corp.

    1        2,703  

Simply Good Foods Co. (The)(a)

    502        12,068  

Sprouts Farmers Market Inc.(a)

    315        8,310  

Sysco Corp.

    2,492        131,702  

Tootsie Roll Industries Inc.

    102        3,233  

TreeHouse Foods Inc.(a)

    448        19,631  

Tyson Foods Inc., Class A

    1,909        117,308  

U.S. Foods Holding Corp.(a)

    833        16,910  

United Natural Foods Inc.(a)

    154        3,057  
    

 

 

 
       2,483,032  
Holding Companies – Diversified — 0.1%             

Cannae Holdings Inc.(a)

    208        7,837  
    

 

 

 
Household Products & Wares — 3.0%             

ACCO Brands Corp.

    2        13  

Central Garden & Pet Co., Class A, NVS(a)

    91        3,153  

Church & Dwight Co. Inc.

    803        77,353  

Clorox Co. (The)

    395        93,421  

Helen of Troy Ltd.(a)

    55        10,354  

Kimberly-Clark Corp.

    720        109,469  
    

 

 

 
       293,763  
Housewares — 0.2%             

Scotts Miracle-Gro Co. (The)

    98        15,540  

Tupperware Brands Corp.

    112        1,728  
    

 

 

 
       17,268  
Machinery — 0.2%             

AGCO Corp.

    161        10,566  

Middleby Corp. (The)(a)

    119        9,884  

Welbilt Inc.(a)

    247        1,502  
    

 

 

 
       21,952  
Manufacturing — 0.1%             

AptarGroup Inc.

    63        7,257  
 

 

 

20  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Manufacturing (continued)            

John Bean Technologies Corp.

    84     $ 7,876  
   

 

 

 
      15,133  
Packaging & Containers — 2.8%            

Amcor PLC(a)

    720       7,416  

Ball Corp.

    1,665       122,594  

Berry Global Group Inc.(a)

    433       21,646  

Crown Holdings Inc.(a)

    638       45,668  

Graphic Packaging Holding Co.

    1,553       21,649  

O-I Glass Inc.

    546       5,700  

Packaging Corp. of America

    135       12,976  

Sealed Air Corp.

    301       10,740  

Silgan Holdings Inc.

    259       9,907  

Sonoco Products Co.

    294       15,211  
   

 

 

 
      273,507  
Pharmaceuticals — 2.5%            

Elanco Animal Health Inc.(a)

    1,027       24,268  

Herbalife Nutrition Ltd.(a)

    321       16,448  

Neogen Corp.(a)

    189       14,509  

Perrigo Co. PLC

    92       4,878  

Prestige Consumer Healthcare Inc.(a)

    154       5,727  

Zoetis Inc.

    1,163       176,404  
   

 

 

 
           242,234  
Real Estate Investment Trusts — 1.4%            

Americold Realty Trust

    589       23,766  

Equinix Inc.

    142       111,538  
   

 

 

 
      135,304  
Retail — 11.7%            

BJ’s Restaurants Inc.

    43       863  

Casey’s General Stores Inc.

    77       12,258  

Cheesecake Factory Inc. (The)

    98       2,352  

Chipotle Mexican Grill Inc.(a)

    112       129,378  

Cracker Barrel Old Country Store Inc.

    35       3,866  

Darden Restaurants Inc.

    176       13,358  

Dunkin’ Brands Group Inc.

    317       21,787  

Freshpet Inc.(a)

    184       17,673  

Jack in the Box Inc.

    63       5,173  
Security   Shares     Value  
Retail (continued)            

McDonald’s Corp.

    2,204     $ 428,193  

Shake Shack Inc., Class A(a)

    71       3,447  

Starbucks Corp.

    4,829       369,563  

Walmart Inc.

    27       3,494  

Wendy’s Co. (The)

    497       11,521  

Wingstop Inc.

    63       9,844  

Yum China Holdings Inc.

    840       43,042  

Yum! Brands Inc.

    861       78,394  
   

 

 

 
      1,154,206  
Toys, Games & Hobbies — 0.1%            

Mattel Inc.(a)

    821       9,121  
   

 

 

 

Total Common Stocks — 99.2%
(Cost: $8,963,850)

      9,783,351  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 2.3%            

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    162,278       162,457  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    66,000       66,000  
   

 

 

 
      228,457  
   

 

 

 

Total Short-Term Investments — 2.3%
(Cost: $228,312)

      228,457  
   

 

 

 

Total Investments in Securities — 101.5%
(Cost: $9,192,162)

      10,011,808  

Other Assets, Less Liabilities — (1.5)%

      (152,457
   

 

 

 

Net Assets — 100.0%

    $ 9,859,351  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 28,021      $ 134,338 (a)     $      $ (47    $ 145      $ 162,457        162,278      $  1,314 (b)     $  —  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     19,000        47,000 (a)                             66,000        66,000        557         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ (47    $ 145      $ 228,457         $ 1,871      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

SCHEDULE OF INVESTMENTS

  21


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Consumer Staples ETF

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 9,783,351        $        $        $ 9,783,351  

Money Market Funds

     228,457                            228,457  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 10,011,808        $             —        $             —        $ 10,011,808  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

22  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Advertising — 0.1%  

Interpublic Group of Companies Inc. (The)

    377     $ 6,805  
   

 

 

 
Airlines — 0.1%  

Alaska Air Group Inc.

    182       6,268  

JetBlue Airways Corp.(a)

    483       4,994  
   

 

 

 
      11,262  
Apparel — 5.7%  

Capri Holdings Ltd.(a)

    582       8,718  

Carter’s Inc.

    245       19,286  

Columbia Sportswear Co.

    126       9,556  

Crocs Inc.(a)

    238       8,554  

Deckers Outdoor Corp.(a)

    131       27,412  

Hanesbrands Inc.

    1,288       18,199  

Nike Inc., Class B

    4,259       415,721  

Oxford Industries Inc.

    84       3,607  

PVH Corp.

    357       17,372  

Ralph Lauren Corp.

    211       15,044  

Skechers U.S.A. Inc., Class A(a)

    588       17,217  

Steven Madden Ltd.

    390       8,260  

Tapestry Inc.

    1,295       17,301  

Under Armour Inc., Class A(a)

    707       7,438  

Under Armour Inc., Class C, NVS(a)

    721       6,842  

VF Corp.

    1,366       82,452  

Wolverine World Wide Inc.

    217       5,217  
   

 

 

 
      688,196  
Beverages — 0.1%  

Constellation Brands Inc., Class A

    46       8,197  
   

 

 

 
Building Materials — 0.2%  

American Woodmark Corp.(a)

    28       2,257  

Masco Corp.

    286       16,348  
   

 

 

 
      18,605  
Chemicals — 0.0%  

Valvoline Inc.

    294       6,033  
   

 

 

 
Commercial Services — 2.0%  

Aaron’s Inc.

    252       13,148  

Avis Budget Group Inc.(a)

    119       3,082  

Bright Horizons Family Solutions Inc.(a)

    35       3,753  

Brink’s Co. (The)

    63       2,794  

Cintas Corp.

    126       38,036  

Euronet Worldwide Inc.(a)

    70       6,730  

FleetCor Technologies Inc.(a)

    24       6,206  

Grand Canyon Education Inc.(a)

    63       5,591  

H&R Block Inc.

    392       5,684  

ManpowerGroup Inc.

    105       7,223  

Monro Inc.(b)

    119       6,700  

PayPal Holdings Inc.(a)

    422       82,741  

Rent-A-Center Inc./TX

    202       5,842  

Rollins Inc.

    210       11,004  

ServiceMaster Global Holdings Inc.(a)

    238       9,732  

Square Inc., Class A(a)

    200       25,970  

WW International Inc.(a)(b)

    63       1,624  
   

 

 

 
      235,860  
Computers — 6.0%  

Apple Inc.

    1,684       715,767  
   

 

 

 
Cosmetics & Personal Care — 3.9%  

Coty Inc., Class A

    359       1,332  
Security   Shares     Value  
Cosmetics & Personal Care (continued)  

Estee Lauder Companies Inc. (The), Class A

    626     $ 123,660  

Inter Parfums Inc.

    54       2,208  

Procter & Gamble Co. (The)

    2,622       343,797  
   

 

 

 
      470,997  
Distribution & Wholesale — 1.0%  

Core-Mark Holding Co. Inc.

    103       2,731  

Fastenal Co.

    654       30,764  

G-III Apparel Group Ltd.(a)

    203       2,008  

HD Supply Holdings Inc.(a)

    217       7,617  

LKQ Corp.(a)

    357       10,064  

Pool Corp.

    77       24,386  

SiteOne Landscape Supply Inc.(a)

    63       8,066  

WW Grainger Inc.

    84       28,688  
   

 

 

 
      114,324  
Diversified Financial Services — 0.7%  

Alliance Data Systems Corp.

    63       2,795  

LendingTree Inc.(a)

    7       2,424  

Mastercard Inc., Class A

    29       8,947  

Visa Inc., Class A

    369       70,258  
   

 

 

 
      84,424  
Entertainment — 0.5%  

Churchill Downs Inc.

    69       9,558  

Cinemark Holdings Inc.

    224       2,650  

Live Nation Entertainment Inc.(a)

    315       14,745  

Madison Square Garden Sports Corp.(a)

    35       5,379  

Marriott Vacations Worldwide Corp.

    62       5,249  

Penn National Gaming Inc.(a)

    43       1,455  

Red Rock Resorts Inc., Class A

    203       2,225  

Scientific Games Corp./DE, Class A(a)

    77       1,353  

SeaWorld Entertainment Inc.(a)

    153       2,214  

Six Flags Entertainment Corp.

    119       2,069  

Vail Resorts Inc.

    91       17,475  
   

 

 

 
      64,372  
Food — 1.5%  

Beyond Meat Inc.(a)

    59       7,428  

Flowers Foods Inc.

    315       7,166  

Grocery Outlet Holding Corp.(a)

    257       11,305  

Kroger Co. (The)

    3,095       107,675  

Performance Food Group Co.(a)

    224       6,277  

Sprouts Farmers Market Inc.(a)

    441       11,634  

Sysco Corp.

    489       25,844  

U.S. Foods Holding Corp.(a)

    378       7,673  
   

 

 

 
      185,002  
Food Service — 0.1%  

Aramark

    560       11,827  
   

 

 

 
Holding Companies – Diversified — 0.0%  

Cannae Holdings Inc.(a)

    105       3,956  
   

 

 

 
Home Builders — 0.1%  

Taylor Morrison Home Corp.(a)

    140       3,283  

Toll Brothers Inc.

    182       6,952  
   

 

 

 
      10,235  
Home Furnishings — 0.1%  

Sleep Number Corp.(a)

    82       3,813  

Tempur Sealy International Inc.(a)

    119       9,633  
   

 

 

 
      13,446  
Household Products & Wares — 0.3%  

Helen of Troy Ltd.(a)

    36       6,777  
 

 

 

SCHEDULE OF INVESTMENTS

  23


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Household Products & Wares (continued)  

Kimberly-Clark Corp.

    182     $ 27,671  

Spectrum Brands Holdings Inc.

    28       1,517  
   

 

 

 
      35,965  
Housewares — 0.2%  

Newell Brands Inc.

    663       10,873  

Scotts Miracle-Gro Co. (The)

    56       8,880  

Tupperware Brands Corp.

    77       1,188  
   

 

 

 
      20,941  
Internet — 23.7%  

Amazon.com Inc.(a)

    754       2,386,170  

Booking Holdings Inc.(a)

    71       118,011  

Cars.com Inc.(a)

    105       853  

Chewy Inc., Class A(a)

    107       5,616  

eBay Inc.

    862       47,651  

Etsy Inc.(a)

    203       24,031  

Expedia Group Inc.

    167       13,529  

Groupon Inc.(a)

    42       645  

Grubhub Inc.(a)

    154       11,125  

MercadoLibre Inc.(a)

    85       95,593  

Pinterest Inc., Class A(a)

    650       22,289  

Stamps.com Inc.(a)

    21       5,466  

Stitch Fix Inc., Class A(a)

    96       2,126  

TripAdvisor Inc.

    175       3,540  

Uber Technologies Inc.(a)

    1,455       44,028  

Wayfair Inc., Class A(a)

    218       58,008  
   

 

 

 
      2,838,681  
Leisure Time — 0.5%  

Carnival Corp.

    915       12,700  

Norwegian Cruise Line Holdings Ltd.(a)

    365       4,979  

Planet Fitness Inc., Class A(a)

    364       19,001  

Polaris Inc.

    49       5,078  

Royal Caribbean Cruises Ltd.

    274       13,346  
   

 

 

 
      55,104  
Lodging — 1.8%  

Boyd Gaming Corp.

    145       3,432  

Choice Hotels International Inc.

    112       9,413  

Extended Stay America Inc.

    301       3,434  

Hilton Grand Vacations Inc.(a)

    147       2,984  

Hilton Worldwide Holdings Inc.

    775       58,164  

Hyatt Hotels Corp., Class A

    112       5,376  

Las Vegas Sands Corp.

    793       34,607  

Marriott International Inc./MD, Class A

    542       45,433  

MGM Resorts International

    1,001       16,106  

Wyndham Destinations Inc.

    287       7,634  

Wyndham Hotels & Resorts Inc.

    335       14,794  

Wynn Resorts Ltd.

    175       12,675  
   

 

 

 
      214,052  
Office Furnishings — 0.0%  

Herman Miller Inc.

    84       1,968  
   

 

 

 
Oil & Gas — 0.1%  

Murphy USA Inc.(a)

    84       11,123  
   

 

 

 
Pharmaceuticals — 0.1%  

Herbalife Nutrition Ltd.(a)

    166       8,506  
   

 

 

 
Real Estate — 0.0%  

RE/MAX Holdings Inc., Class A

    49       1,586  
   

 

 

 
Security   Shares     Value  
Real Estate Investment Trusts — 0.2%  

Apple Hospitality REIT Inc.

    294     $ 2,593  

Host Hotels & Resorts Inc.

    931       10,036  

Macerich Co. (The)(b)

    191       1,457  

Park Hotels & Resorts Inc.

    210       1,737  

Ruth’s Hospitality Group Inc.

    126       844  

Ryman Hospitality Properties Inc.

    56       1,793  

Tailored Brands Inc.

    245       74  

Taubman Centers Inc.

    126       4,879  
   

 

 

 
      23,413  
Retail — 49.9%  

Abercrombie & Fitch Co., Class A

    363       3,496  

Advance Auto Parts Inc.

    252       37,835  

American Eagle Outfitters Inc.

    819       8,190  

Ascena Retail Group Inc.(a)

    45       32  

At Home Group Inc.(a)

    204       2,534  

AutoNation Inc.(a)

    147       7,547  

AutoZone Inc.(a)

    77       92,971  

Beacon Roofing Supply Inc.(a)

    84       2,617  

Bed Bath & Beyond Inc.

    599       6,481  

Best Buy Co. Inc.

    743       73,995  

Big Lots Inc.

    217       8,537  

BJ’s Restaurants Inc.

    63       1,264  

BJ’s Wholesale Club Holdings Inc.(a)

    491       19,665  

Bloomin’ Brands Inc.

    336       3,871  

Boot Barn Holdings Inc.(a)

    151       2,923  

Brinker International Inc.

    167       4,491  

Buckle Inc. (The)

    133       2,132  

Burlington Stores Inc.(a)

    318       59,784  

Caleres Inc.

    175       1,104  

CarMax Inc.(a)

    476       46,158  

Carvana Co.(a)

    123       19,059  

Casey’s General Stores Inc.

    147       23,401  

Cheesecake Factory Inc. (The)

    147       3,528  

Chipotle Mexican Grill Inc.(a)

    71       82,016  

Costco Wholesale Corp.

    1,773       577,165  

Cracker Barrel Old Country Store Inc.

    98       10,826  

Darden Restaurants Inc.

    469       35,597  

Dave & Buster’s Entertainment Inc.

    148       1,826  

Denny’s Corp.(a)

    252       2,239  

Designer Brands Inc. , Class A

    336       1,986  

Dick’s Sporting Goods Inc.

    302       13,777  

Dine Brands Global Inc.

    70       3,180  

Dollar General Corp.

    1,092       207,917  

Dollar Tree Inc.(a)

    1,119       104,459  

Domino’s Pizza Inc.

    145       56,058  

Dunkin’ Brands Group Inc.

    175       12,028  

FirstCash Inc.

    133       7,666  

Five Below Inc.(a)

    273       29,732  

Floor & Decor Holdings Inc., Class A(a)

    245       16,145  

Foot Locker Inc.

    448       13,167  

Gap Inc. (The)

    1,463       19,560  

Genesco Inc.(a)

    98       1,524  

Genuine Parts Co.

    217       19,563  

Home Depot Inc. (The)

    3,702       982,844  

Jack in the Box Inc.

    79       6,487  

Kohl’s Corp.

    799       15,213  

L Brands Inc.

    1,230       30,024  

La-Z-Boy Inc.

    126       3,586  

Lithia Motors Inc., Class A

    49       11,228  

Lowe’s Companies Inc.

    2,518       374,955  
 

 

 

24  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Retail (continued)  

Lululemon Athletica Inc.(a)

    545     $ 177,447  

Macy’s Inc.

    1,817       11,011  

McDonald’s Corp.

    1,880       365,246  

MSC Industrial Direct Co. Inc., Class A

    70       4,621  

National Vision Holdings Inc.(a)

    175       5,598  

Nordstrom Inc.

    547       7,488  

Ollie’s Bargain Outlet Holdings Inc.(a)

    285       29,953  

O’Reilly Automotive Inc.(a)

    289       137,963  

Papa John’s International Inc.

    82       7,763  

PriceSmart Inc.

    98       6,406  

Qurate Retail Inc. Series A(a)

    370       4,037  

RH(a)

    79       22,707  

Ross Stores Inc.

    1,694       151,901  

Sally Beauty Holdings Inc.(a)

    567       6,583  

Shake Shack Inc., Class A(a)

    84       4,078  

Signet Jewelers Ltd.

    251       2,696  

Starbucks Corp.

    2,579       197,371  

Target Corp.

    2,204       277,440  

Texas Roadhouse Inc.

    252       14,160  

Tiffany & Co.

    416       52,150  

TJX Companies Inc. (The)

    5,384       279,914  

Tractor Supply Co.

    482       68,801  

Ulta Beauty Inc.(a)

    269       51,914  

Urban Outfitters Inc.(a)

    350       5,789  

Walgreens Boots Alliance Inc.

    1,807       73,563  

Walmart Inc.

    5,624       727,746  

Wendy’s Co. (The)

    595       13,792  

Williams-Sonoma Inc.

    355       30,928  

Wingstop Inc.

    84       13,125  

Yum China Holdings Inc.

    1,102       56,466  

Yum! Brands Inc.

    1,035       94,237  
   

 

 

 
      5,975,277  
Software — 0.1%  

Intuit Inc.

    35       10,723  

Take-Two Interactive Software Inc.(a)

    33       5,413  
   

 

 

 
      16,136  
Security   Shares     Value  
Textiles — 0.0%  

UniFirst Corp./MA

    28     $ 5,221  
   

 

 

 
Toys, Games & Hobbies — 0.2%  

Hasbro Inc.

    168       12,224  

Mattel Inc.(a)

    530       5,888  
   

 

 

 
      18,112  
Transportation — 0.4%  

FedEx Corp.

    294       49,510  
   

 

 

 

Total Common Stocks — 99.6%
(Cost: $10,336,966)

 

    11,924,903  
   

 

 

 

Short-Term Investments

 

 
Money Market Funds — 0.4%        

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    4,967       4,972  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    45,000       45,000  
   

 

 

 
      49,972  
   

 

 

 

Total Short-Term Investments — 0.4%
(Cost: $49,963)

 

    49,972  
   

 

 

 

Total Investments in Securities — 100.0%
(Cost: $10,386,929)

 

    11,974,875  

Other Assets, Less Liabilities — 0.0%

 

    5,661  
   

 

 

 

Net Assets — 100.0%

 

  $ 11,980,536  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 27,828      $      $ (23,160 )(a)     $ 298      $ 6      $ 4,972        4,967      $ 991 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     29,000        16,000 (a)                            45,000        45,000        932         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ 298      $ 6      $ 49,972         $ 1,923      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

SCHEDULE OF INVESTMENTS

  25


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Discretionary Spending ETF

 

Fair Value Measurements (continued)

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 11,924,903        $        $        $ 11,924,903  

Money Market Funds

     49,972                            49,972  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 11,974,875        $             —        $             —        $ 11,974,875  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

26  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Banks — 39.5%  

Ameris Bancorp.

    64     $ 1,477  

Associated Banc-Corp.

    347       4,456  

Atlantic Union Bankshares Corp.

    140       3,160  

BancFirst Corp.

    46       2,004  

Bank of America Corp.

    7,440       185,107  

Bank of Hawaii Corp.

    94       5,323  

Bank of New York Mellon Corp. (The)

    1,222       43,809  

Bank OZK

    226       5,435  

BankUnited Inc.

    216       4,350  

Banner Corp.

    52       1,842  

BOK Financial Corp.

    53       2,952  

Bryn Mawr Bank Corp.

    63       1,641  

Cathay General Bancorp.

    180       4,352  

CIT Group Inc.

    167       3,168  

Citigroup Inc.

    2,773       138,678  

Citizens Financial Group Inc.

    830       20,592  

City Holding Co.

    40       2,498  

Columbia Banking System Inc.

    153       4,426  

Comerica Inc.

    264       10,169  

Commerce Bancshares Inc.

    193       11,051  

Community Bank System Inc.

    114       6,410  

ConnectOne Bancorp. Inc.

    76       1,048  

Cullen/Frost Bankers Inc.

    118       8,503  

CVB Financial Corp.

    243       4,391  

Eagle Bancorp. Inc.

    67       2,015  

East West Bancorp. Inc.

    288       9,982  

Enterprise Financial Services Corp.

    58       1,686  

Fifth Third Bancorp.

    1,330       26,414  

First BanCorp./Puerto Rico

    384       2,089  

First Bancorp./Southern Pines NC

    71       1,467  

First Busey Corp.

    112       1,915  

First Citizens BancShares Inc./NC, Class A

    12       5,111  

First Commonwealth Financial Corp.

    268       2,109  

First Financial Bancorp.

    210       2,922  

First Financial Bankshares Inc.

    284       8,497  

First Hawaiian Inc.

    261       4,536  

First Horizon National Corp.

    1,165       10,800  

First Interstate BancSystem Inc., Class A

    83       2,416  

First Midwest Bancorp. Inc.

    230       2,791  

Flagstar Bancorp. Inc.

    62       1,946  

FNB Corp.

    695       5,150  

Fulton Financial Corp.

    382       3,705  

Glacier Bancorp. Inc.

    172       6,073  

Goldman Sachs Group Inc. (The)

    522       103,335  

Great Western Bancorp. Inc.

    127       1,651  

Hancock Whitney Corp.

    169       3,221  

Hanmi Financial Corp.

    78       720  

Heartland Financial USA Inc.

    71       2,218  

Heritage Financial Corp./WA

    75       1,419  

Hilltop Holdings Inc.

    160       3,115  

Home BancShares Inc./AR

    318       5,193  

Hope Bancorp Inc.

    282       2,377  

Huntington Bancshares Inc./OH

    1,901       17,622  

Independent Bank Corp.

    58       3,742  

Independent Bank Group Inc.

    43       1,889  

International Bancshares Corp.

    134       4,076  

JPMorgan Chase & Co.

    1,820       175,885  

KeyCorp.

    1,838       22,074  
Security   Shares      Value  
Banks (continued)  

Lakeland Bancorp. Inc.

    132      $ 1,344  

Lakeland Financial Corp.

    67        2,965  

M&T Bank Corp.

    137        14,515  

Meta Financial Group Inc.

    57        1,064  

Morgan Stanley

    1,803        88,131  

National Bank Holdings Corp., Class A

    71        1,972  

NBT Bancorp. Inc.

    113        3,366  

Northern Trust Corp.

    350        27,423  

OFG Bancorp

    94        1,230  

Old National Bancorp./IN

    329        4,603  

PacWest Bancorp.

    229        4,185  

Park National Corp.

    33        2,830  

Pinnacle Financial Partners Inc.

    147        5,824  

Popular Inc.

    173        6,420  

Prosperity Bancshares Inc.

    173        9,612  

Regions Financial Corp.

    1,846        20,048  

Renasant Corp.

    114        2,648  

S&T Bancorp. Inc.

    84        1,806  

Sandy Spring Bancorp. Inc.

    78        1,803  

Seacoast Banking Corp. of Florida(a)

    99        1,869  

ServisFirst Bancshares Inc.

    94        3,440  

Simmons First National Corp., Class A

    177        2,936  

South State Corp.

    133        6,339  

Southside Bancshares Inc.

    85        2,355  

State Street Corp.

    597        38,083  

SVB Financial Group(a)

    95        21,306  

Synovus Financial Corp.

    297        5,985  

TCF Financial Corp.

    279        7,670  

Texas Capital Bancshares Inc.(a)

    54        1,794  

Tompkins Financial Corp.

    38        2,452  

Truist Financial Corp.

    2,509        93,987  

Trustmark Corp.

    72        1,622  

U.S. Bancorp.

    2,492        91,805  

UMB Financial Corp.

    94        4,681  

Umpqua Holdings Corp.

    398        4,318  

United Community Banks Inc./GA

    128        2,295  

Valley National Bancorp.

    594        4,437  

Veritex Holdings Inc.

    64        1,070  

Webster Financial Corp.

    186        5,072  

Wells Fargo & Co.

    6,861        166,448  

WesBanco Inc.

    103        2,043  

Westamerica Bancorp.

    61        3,682  

Western Alliance Bancorp.

    152        5,464  

Wintrust Financial Corp.

    116        4,965  

Zions Bancorp. N.A.

    357        11,592  
    

 

 

 
       1,626,502  
Commercial Services — 5.9%  

Automatic Data Processing Inc.

    211        28,044  

Avalara Inc.(a)

    26        3,496  

CoreLogic Inc.

    64        4,362  

Equifax Inc.

    78        12,680  

Euronet Worldwide Inc.(a)

    25        2,404  

EVERTEC Inc.

    66        2,049  

FleetCor Technologies Inc.(a)

    42        10,860  

FTI Consulting Inc.(a)

    21        2,508  

Global Payments Inc.

    165        29,373  

Grand Canyon Education Inc.(a)

    23        2,041  

Green Dot Corp., Class A(a)

    57        2,889  

HealthEquity Inc.(a)

    37        1,908  

Insperity Inc.

    29        1,939  
 

 

 

SCHEDULE OF INVESTMENTS

  27


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Commercial Services (continued)  

MarketAxess Holdings Inc.

    29     $ 14,984  

Moody’s Corp.

    135       37,975  

Morningstar Inc.

    17       2,857  

S&P Global Inc.

    140       49,035  

Service Corp. International

    111       4,813  

Verisk Analytics Inc.

    127       23,966  

WEX Inc.(a)

    37       5,860  
   

 

 

 
      244,043  
Computers — 0.1%  

Genpact Ltd.

    66       2,628  
   

 

 

 
Diversified Financial Services — 14.0%  

Affiliated Managers Group Inc.(b)

    61       4,196  

Alliance Data Systems Corp.

    30       1,331  

Ally Financial Inc.

    601       12,080  

American Express Co.

    809       75,496  

Ameriprise Financial Inc.

    187       28,729  

Ares Management Corp., Class A

    76       3,035  

Artisan Partners Asset Management Inc., Class A

    70       2,536  

BGC Partners Inc., Class A

    217       601  

Boston Private Financial Holdings Inc.

    128       753  

Capital One Financial Corp.

    723       46,127  

Cboe Global Markets Inc.

    101       8,858  

Charles Schwab Corp. (The)

    1,668       55,294  

CME Group Inc.

    224       37,224  

Cohen & Steers Inc.

    36       2,167  

Credit Acceptance Corp.(a)

    16       7,487  

Discover Financial Services

    392       19,377  

Eaton Vance Corp., NVS

    167       6,035  

Evercore Inc., Class A

    38       2,101  

Federated Investors Inc., Class B

    132       3,480  

Franklin Resources Inc.

    372       7,831  

Hamilton Lane Inc., Class A

    24       1,734  

Houlihan Lokey Inc.

    40       2,192  

Interactive Brokers Group Inc., Class A

    71       3,522  

Intercontinental Exchange Inc.

    438       42,390  

Invesco Ltd.

    336       3,373  

Janus Henderson Group PLC

    264       5,515  

Jefferies Financial Group Inc.

    307       4,973  

KKR & Co. Inc.

    539       19,064  

Legg Mason Inc.

    126       6,299  

LendingTree Inc.(a)(b)

    5       1,731  

LPL Financial Holdings Inc.

    104       8,218  

Mastercard Inc., Class A

    80       24,682  

Moelis & Co., Class A

    41       1,221  

Nasdaq Inc.

    105       13,788  

Navient Corp.

    271       2,157  

OneMain Holdings Inc.

    116       3,329  

Raymond James Financial Inc.

    207       14,382  

Santander Consumer USA Holdings Inc.(b)

    110       2,020  

SEI Investments Co.

    153       8,007  

SLM Corp.

    711       4,814  

Stifel Financial Corp.

    123       5,963  

Synchrony Financial

    753       16,664  

T Rowe Price Group Inc.

    271       37,425  

Tradeweb Markets Inc., Class A

    54       2,920  

Virtu Financial Inc., Class A

    101       2,505  

Visa Inc., Class A

    23       4,379  

Waddell & Reed Financial Inc., Class A

    137       1,999  
Security   Shares      Value  
Diversified Financial Services (continued)  

Western Union Co. (The)

    288      $ 6,993  
    

 

 

 
       576,997  
Electric — 0.1%  

Hawaiian Electric Industries Inc.

    139        5,040  
    

 

 

 
Engineering & Construction — 0.1%  

frontdoor Inc.(a)

    55        2,310  
    

 

 

 
Forest Products & Paper — 0.1%  

International Paper Co.

    156        5,427  
    

 

 

 
Health Care – Services — 3.8%  

Anthem Inc.

    133        36,416  

Centene Corp.(a)

    109        7,112  

Cigna Corp.(a)

    275        47,490  

Humana Inc.

    5        1,962  

Molina Healthcare Inc.(a)

    42        7,757  

UnitedHealth Group Inc.

    189        57,226  
    

 

 

 
       157,963  
Home Builders — 0.3%  

NVR Inc.(a)

    3        11,790  
    

 

 

 
Household Products & Wares — 0.0%  

Spectrum Brands Holdings Inc.

    8        433  
    

 

 

 
Insurance — 26.2%  

Aflac Inc.

    1,181        42,008  

Alleghany Corp.

    26        13,580  

Allstate Corp. (The)

    516        48,705  

American Financial Group Inc./OH

    139        8,447  

American International Group Inc.

    1,525        49,013  

American National Group Inc.

    22        1,620  

Aon PLC, Class A

    173        35,503  

Arch Capital Group Ltd.(a)

    563        17,312  

Argo Group International Holdings Ltd.

    56        1,877  

Arthur J Gallagher & Co.

    250        26,872  

Assurant Inc.

    74        7,953  

Assured Guaranty Ltd.

    85        1,856  

Athene Holding Ltd., Class A(a)(b)

    340        10,965  

Axis Capital Holdings Ltd.

    134        5,376  

Berkshire Hathaway Inc., Class B(a)

    586        114,727  

Brighthouse Financial Inc.(a)

    154        4,364  

Brown & Brown Inc.

    331        15,051  

Cincinnati Financial Corp.

    296        23,067  

CNA Financial Corp.

    66        2,198  

CNO Financial Group Inc.

    209        3,156  

eHealth Inc.(a)

    16        1,106  

Employers Holdings Inc.

    56        1,821  

Enstar Group Ltd.(a)

    19        3,191  

Equitable Holdings Inc.

    602        12,317  

Erie Indemnity Co., Class A, NVS

    27        5,673  

Essent Group Ltd.

    131        4,694  

Everest Re Group Ltd.

    71        15,534  

Fidelity National Financial Inc.

    416        13,462  

First American Financial Corp.

    190        9,692  

Genworth Financial Inc., Class A(a)

    1,014        2,069  

Globe Life Inc.

    198        15,761  

Hanover Insurance Group Inc. (The)

    81        8,252  

Hartford Financial Services Group Inc. (The)

    637        26,958  

Horace Mann Educators Corp.

    85        3,194  

James River Group Holdings Ltd.

    48        2,223  
 

 

 

28  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Insurance (continued)  

Kemper Corp.

    121     $ 9,501  

Kinsale Capital Group Inc.

    39       7,601  

Lincoln National Corp.

    371       13,827  

Loews Corp.

    240       8,738  

Markel Corp.(a)

    19       19,846  

Marsh & McLennan Companies Inc.

    586       68,328  

Mercury General Corp.

    60       2,575  

MetLife Inc.

    1,308       49,508  

MGIC Investment Corp.

    653       5,400  

National General Holdings Corp.

    118       4,011  

NMI Holdings Inc., Class A(a)

    139       2,157  

Old Republic International Corp.

    379       6,091  

Palomar Holdings Inc.(a)

    39       3,562  

Primerica Inc.

    56       6,701  

Principal Financial Group Inc.

    503       21,342  

ProAssurance Corp.

    105       1,544  

Progressive Corp. (The)

    981       88,624  

Prudential Financial Inc.

    723       45,817  

Radian Group Inc.

    321       4,789  

RenaissanceRe Holdings Ltd.

    75       13,528  

RLI Corp.

    90       7,932  

Safety Insurance Group Inc.

    33       2,497  

Selective Insurance Group Inc.

    112       6,086  

Travelers Companies Inc. (The)

    454       51,947  

Universal Insurance Holdings Inc.

    64       1,121  

Unum Group

    394       6,789  

Voya Financial Inc.

    255       12,597  

White Mountains Insurance Group Ltd.

    6       5,281  

Willis Towers Watson PLC

    116       24,361  

WR Berkley Corp.

    283       17,475  
   

 

 

 
      1,079,173  
Internet — 0.8%  

E*TRADE Financial Corp.

    370       18,785  

Lyft Inc., Class A(a)

    159       4,647  

TD Ameritrade Holding Corp.

    275       9,870  
   

 

 

 
      33,302  
Machinery — 0.9%  

Caterpillar Inc.

    257       34,150  

Vertiv Holdings Co.(a)

    196       2,842  
   

 

 

 
      36,992  
Media — 0.1%  

FactSet Research Systems Inc.

    16       5,541  
   

 

 

 
Pharmaceuticals — 0.8%  

CVS Health Corp.

    491       30,904  
   

 

 

 
Private Equity — 0.7%  

Blackstone Group Inc. (The), Class A

    499       26,587  
   

 

 

 
Real Estate Investment Trusts — 0.7%  

AGNC Investment Corp.

    213       2,897  

Annaly Capital Management Inc.

    930       6,891  

MFA Financial Inc.

    382       1,005  

New Residential Investment Corp.

    268       2,125  

Two Harbors Investment Corp.

    150       814  

Weyerhaeuser Co.

    492       13,683  
   

 

 

 
      27,415  
Security   Shares     Value  
Retail — 0.1%  

FirstCash Inc.

    30     $ 1,729  
   

 

 

 
Savings & Loans — 1.2%  

Axos Financial Inc.(a)

    95       2,129  

Berkshire Hills Bancorp. Inc.

    75       747  

Brookline Bancorp. Inc.

    175       1,679  

Capitol Federal Financial Inc.

    292       2,818  

Investors Bancorp. Inc.

    501       4,068  

Meridian Bancorp. Inc.

    113       1,289  

New York Community Bancorp. Inc.

    937       9,867  

Northwest Bancshares Inc.

    224       2,206  

OceanFirst Financial Corp.

    97       1,486  

Pacific Premier Bancorp. Inc.

    95       1,996  

People’s United Financial Inc.

    759       8,190  

Provident Financial Services Inc.

    140       1,911  

Sterling Bancorp./DE

    450       5,062  

Washington Federal Inc.

    174       4,061  

WSFS Financial Corp.

    118       3,367  
   

 

 

 
      50,876  
Semiconductors — 0.2%  

Intel Corp.

    155       7,398  
   

 

 

 
Software — 3.5%  

Black Knight Inc.(a)

    48       3,596  

Broadridge Financial Solutions Inc.

    90       12,091  

Fidelity National Information Services Inc.

    456       66,717  

Fiserv Inc.(a)

    277       27,642  

Jack Henry & Associates Inc.

    11       1,961  

MSCI Inc.

    44       16,543  

Paychex Inc.

    155       11,148  

SS&C Technologies Holdings Inc.

    91       5,232  
   

 

 

 
      144,930  
   

 

 

 

Total Common Stocks — 99.1%
(Cost: $4,879,934)

 

    4,077,980  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.9%

 

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    8,494       8,503  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    30,000       30,000  
   

 

 

 
      38,503  
   

 

 

 

Total Short-Term Investments — 0.9%
(Cost: $38,504)

 

    38,503  
   

 

 

 

Total Investments in Securities — 100.0%
(Cost: $4,918,438)

 

    4,116,483  

Other Assets, Less Liabilities — (0.0)%

 

    (1,586
   

 

 

 

Net Assets — 100.0%

 

  $ 4,114,897  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

SCHEDULE OF INVESTMENTS

  29


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Financials ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 1,490      $ 6,953 (a)     $      $ 61      $ (1    $ 8,503        8,494      $ 91 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     24,000        6,000 (a)                            30,000        30,000        331         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ 61      $ (1    $ 38,503         $ 422      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 4,077,980        $        $        $ 4,077,980  

Money Market Funds

     38,503                            38,503  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 4,116,483        $             —        $             —        $ 4,116,483  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

30  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Biotechnology — 4.0%  

Amgen Inc.

    216     $ 52,849  

Bio-Rad Laboratories Inc., Class A(a)

    97       50,914  

Exact Sciences Corp.(a)

    748       70,873  

Guardant Health Inc.(a)

    244       20,784  

Illumina Inc.(a)(b)

    910       347,766  

Livongo Health Inc.(a)

    197       25,068  

Myriad Genetics Inc.(a)

    414       4,997  

NeoGenomics Inc.(a)

    540       20,644  

Veracyte Inc.(a)

    315       11,236  
   

 

 

 
      605,131  
Commercial Services — 0.5%  

Adtalem Global Education Inc.(a)

    179       6,147  

AMN Healthcare Services Inc.(a)

    297       16,317  

Bright Horizons Family Solutions Inc.(a)

    144       15,443  

Grand Canyon Education Inc.(a)

    137       12,157  

HMS Holdings Corp.(a)

    585       19,013  

Laureate Education Inc., Class A(a)

    306       3,880  

Strategic Education Inc.

    45       5,679  
   

 

 

 
      78,636  
Computers — 0.3%  

Leidos Holdings Inc.

    188       17,890  

Maximus Inc.

    269       19,963  
   

 

 

 
      37,853  
Electrical Components & Equipment — 0.1%  

Novanta Inc.(a)

    161       16,692  
   

 

 

 
Electronics — 1.2%  

Agilent Technologies Inc.

    1,002       96,523  

OSI Systems Inc.(a)

    81       5,748  

PerkinElmer Inc.

    425       50,537  

Waters Corp.(a)

    163       34,743  
   

 

 

 
      187,551  
Environmental Control — 0.0%  

Stericycle Inc.(a)

    125       7,554  
   

 

 

 
Food Service — 0.1%  

Healthcare Services Group Inc.

    323       8,459  
   

 

 

 
Health Care – Products — 47.4%            

10X Genomics Inc., Class A(a)

    118       11,608  

Abbott Laboratories

    12,649       1,272,995  

ABIOMED Inc.(a)

    279       83,683  

Adaptive Biotechnologies Corp.(a)

    152       5,673  

Align Technology Inc.(a)

    206       60,527  

AngioDynamics Inc.(a)

    216       1,784  

AtriCure Inc.(a)

    216       8,815  

Atrion Corp.

    9       5,581  

Avanos Medical Inc.(a)

    180       5,521  

Avantor Inc.(a)

    674       14,882  

Axogen Inc.(a)

    99       1,126  

Baxter International Inc.

    1,692       146,155  

Bio-Techne Corp.

    126       34,670  

BioTelemetry Inc.(a)

    207       8,810  

Boston Scientific Corp.(a)

    9,944       383,540  

Bruker Corp.

    342       15,260  

Cardiovascular Systems Inc.(a)

    189       5,761  

CareDx Inc.(a)

    245       8,171  

Cooper Companies Inc. (The)

    297       84,030  
Security   Shares     Value  
Health Care – Products (continued)  

CryoLife Inc.(a)(b)

    216     $ 4,192  

Cutera Inc.(a)

    63       896  

Danaher Corp.

    2,847       580,219  

Dentsply Sirona Inc.

    755       33,673  

Edwards Lifesciences Corp.(a)

    4,347       340,848  

GenMark Diagnostics Inc.(a)

    414       7,394  

Glaukos Corp.(a)

    126       5,506  

Globus Medical Inc., Class A(a)

    531       25,584  

Haemonetics Corp.(a)

    216       18,934  

Henry Schein Inc.(a)

    713       49,004  

Hill-Rom Holdings Inc.

    326       31,694  

Hologic Inc.(a)

    1,396       97,413  

ICU Medical Inc.(a)

    90       16,536  

IDEXX Laboratories Inc.(a)

    357       141,997  

Inogen Inc.(a)

    117       3,592  

Inspire Medical Systems Inc.(a)

    110       10,930  

Insulet Corp.(a)

    404       82,157  

Integer Holdings Corp.(a)

    135       8,879  

Integra LifeSciences Holdings Corp.(a)

    378       18,049  

Intersect ENT Inc.(a)

    99       1,702  

Intuitive Surgical Inc.(a)

    788       540,127  

iRhythm Technologies Inc.(a)

    168       20,913  

LeMaitre Vascular Inc.(b)

    99       2,904  

LivaNova PLC(a)

    325       15,125  

Luminex Corp.

    207       7,535  

Masimo Corp.(a)

    333       73,300  

Medtronic PLC

    9,253       892,729  

Merit Medical Systems Inc.(a)

    306       13,684  

Natera Inc.(a)

    388       18,632  

Natus Medical Inc.(a)

    189       3,512  

Nevro Corp.(a)

    144       19,146  

Novocure Ltd.(a)

    225       17,053  

NuVasive Inc.(a)

    324       18,513  

OraSure Technologies Inc.(a)

    351       6,371  

Orthofix Medical Inc.(a)

    107       3,286  

Patterson Companies Inc.

    362       9,615  

Penumbra Inc.(a)

    189       41,941  

Quidel Corp.(a)

    180       50,845  

ResMed Inc.

    890       180,234  

Shockwave Medical Inc.(a)

    136       6,707  

Silk Road Medical Inc.(a)

    161       7,480  

STAAR Surgical Co.(a)

    242       14,082  

Steris PLC

    224       35,757  

Stryker Corp.

    2,279       440,531  

Tactile Systems Technology Inc.(a)

    119       4,877  

Tandem Diabetes Care Inc.(a)

    308       32,174  

Teleflex Inc.

    295       110,064  

Thermo Fisher Scientific Inc.

    1,575       651,971  

Varex Imaging Corp.(a)

    153       2,399  

Varian Medical Systems Inc.(a)

    414       59,086  

Wright Medical Group NV(a)(b)

    522       15,670  

Zimmer Biomet Holdings Inc.

    1,149       154,954  
   

 

 

 
      7,109,008  
Health Care – Services — 25.6%  

Acadia Healthcare Co. Inc.(a)

    576       17,171  

Addus HomeCare Corp.(a)

    74       7,134  

Amedisys Inc.(a)

    244       57,135  

Anthem Inc.

    1,304       357,035  

Centene Corp.(a)

    3,247       211,867  

Charles River Laboratories International Inc.(a)

    81       16,118  
 

 

 

SCHEDULE OF INVESTMENTS

  31


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Health Care – Services (continued)  

Chemed Corp.

    64     $ 31,500  

Cigna Corp.(a)

    1,540       265,943  

DaVita Inc.(a)

    540       47,191  

Encompass Health Corp.

    735       50,039  

Ensign Group Inc. (The)

    230       10,578  

Envista Holdings Corp.(a)

    510       11,154  

HCA Healthcare Inc.

    1,821       230,611  

Humana Inc.

    808       317,100  

Invitae Corp.(a)

    442       12,906  

IQVIA Holdings Inc.(a)

    595       94,242  

Laboratory Corp. of America Holdings(a)

    542       104,563  

LHC Group Inc.(a)

    190       37,071  

Magellan Health Inc.(a)

    108       8,010  

MEDNAX Inc.(a)

    605       12,088  

Medpace Holdings Inc.(a)

    65       7,758  

Molina Healthcare Inc.(a)

    140       25,858  

National HealthCare Corp.

    72       4,271  

Quest Diagnostics Inc.

    768       97,590  

Select Medical Holdings Corp.(a)

    792       15,080  

Syneos Health Inc.(a)

    108       6,738  

Teladoc Health Inc.(a)

    288       68,437  

Tenet Healthcare Corp.(a)(b)

    657       17,371  

U.S. Physical Therapy Inc.

    108       8,970  

UnitedHealth Group Inc.

    5,396       1,633,801  

Universal Health Services Inc., Class B

    505       55,499  
   

 

 

 
      3,840,829  
Household Products & Wares — 0.3%  

Church & Dwight Co. Inc.

    511       49,225  
   

 

 

 
Pharmaceuticals — 17.1%  

AbbVie Inc.

    1,528       145,022  

AmerisourceBergen Corp.

    664       66,526  

Bausch Health Companies Inc.(a)(b)

    162       2,960  

Becton Dickinson and Co.

    1,737       488,687  

Cardinal Health Inc.

    1,500       81,930  

CVS Health Corp.

    6,100       383,934  

DexCom Inc.(a)

    537       233,885  

Eli Lilly & Co.

    309       46,440  

Johnson & Johnson

    5,089       741,773  

McKesson Corp.

    704       105,713  

Neogen Corp.(a)

    81       6,218  

Perrigo Co. PLC

    132       6,999  

Pfizer Inc.

    5,287       203,444  

PRA Health Sciences Inc.(a)

    126       13,426  

Premier Inc., Class A(a)

    423       14,792  

Zoetis Inc.

    154       23,359  
   

 

 

 
      2,565,108  
Security   Shares     Value  
Real Estate Investment Trusts — 1.3%  

Healthpeak Properties Inc.

    1,016     $ 27,727  

Medical Properties Trust Inc.

    2,079       41,850  

National Health Investors Inc.

    180       11,160  

Omega Healthcare Investors Inc.

    466       15,089  

Physicians Realty Trust

    738       13,314  

Sabra Health Care REIT Inc.

    720       10,613  

Ventas Inc.

    862       33,066  

Welltower Inc.

    809       43,330  
   

 

 

 
      196,149  
Retail — 0.6%  

National Vision Holdings Inc.(a)

    172       5,502  

Walgreens Boots Alliance Inc.

    1,928       78,489  
   

 

 

 
      83,991  
Software — 0.9%  

Allscripts Healthcare Solutions Inc.(a)

    817       7,353  

Cerner Corp.

    1,459       101,328  

Change Healthcare Inc.(a)

    887       10,342  

Omnicell Inc.(a)

    179       12,582  

Tabula Rasa HealthCare Inc.(a)(b)

    90       5,058  
   

 

 

 
      136,663  
   

 

 

 

Total Common Stocks — 99.4%
(Cost: $12,675,936)

 

    14,922,849  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 2.0%  

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    227,802       228,052  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    66,000       66,000  
   

 

 

 
      294,052  
   

 

 

 

Total Short-Term Investments — 2.0%
(Cost: $294,045)

 

    294,052  
   

 

 

 

Total Investments in Securities — 101.4%
(Cost: $12,969,981)

 

    15,216,901  

Other Assets, Less Liabilities — (1.4)%

 

    (210,249
   

 

 

 

Net Assets — 100.0%

 

  $ 15,006,652  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

32  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Healthcare Staples ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 250,070      $      $ (22,329 )(a)     $ 310      $ 1      $ 228,052        227,802      $ 1,094 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     50,000        16,000 (a)                            66,000        66,000        715         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ 310      $ 1      $ 294,052         $ 1,809      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 14,922,849        $        $        $ 14,922,849  

Money Market Funds

     294,052                            294,052  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 15,216,901        $             —        $             —        $ 15,216,901  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS

  33


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Biotechnology — 46.8%  

Abeona Therapeutics Inc.(a)

    476     $ 1,357  

ACADIA Pharmaceuticals Inc.(a)

    1,932       80,313  

Acceleron Pharma Inc.(a)

    924       91,633  

Achillion Pharmaceuticals Inc.(b)(c)

    624       287  

Acorda Therapeutics Inc.(a)

    714       449  

Aduro Biotech Inc.(a)

    644       1,816  

Adverum Biotechnologies Inc.(a)

    1,063       17,827  

Agenus Inc.(a)

    1,218       3,703  

Albireo Pharma Inc.(a)

    289       8,167  

Alder Biopharmaceuticals Inc.(b)

    312       275  

Alexion Pharmaceuticals Inc.(a)

    3,288       336,987  

Allakos Inc.(a)

    475       35,658  

Allogene Therapeutics Inc.(a)

    1,220       44,737  

Alnylam Pharmaceuticals Inc.(a)

    2,216       323,004  

AMAG Pharmaceuticals Inc.(a)

    448       4,281  

Amgen Inc.

    4,150       1,015,381  

Amicus Therapeutics Inc.(a)

    5,105       73,767  

AnaptysBio Inc.(a)

    238       4,274  

ANI Pharmaceuticals Inc.(a)

    98       2,902  

Apellis Pharmaceuticals Inc.(a)

    1,180       30,550  

Applied Therapeutics Inc.(a)

    247       6,373  

Aprea Therapeutics Inc.(a)

    296       8,119  

Arcus Biosciences Inc.(a)

    999       19,660  

Ardelyx Inc.(a)

    1,203       6,797  

Arena Pharmaceuticals Inc.(a)

    1,109       68,082  

Arrowhead Pharmaceuticals Inc.(a)

    1,846       79,507  

Assembly Biosciences Inc.(a)

    308       6,838  

Atara Biotherapeutics Inc.(a)

    1,360       16,850  

Athersys Inc.(a)

    3,446       8,822  

Avrobio Inc.(a)

    421       7,136  

BioCryst Pharmaceuticals Inc.(a)(c)

    3,270       13,309  

Biogen Inc.(a)

    2,699       741,388  

Biohaven Pharmaceutical Holding Co. Ltd.(a)(c)

    502       32,148  

BioMarin Pharmaceutical Inc.(a)

    3,422       409,990  

Bio-Rad Laboratories Inc., Class A(a)

    28       14,697  

Bluebird Bio Inc.(a)

    1,395       84,677  

Blueprint Medicines Corp.(a)

    993       72,668  

Bridgebio Pharma Inc.(a)

    1,358       38,214  

Calithera Biosciences Inc.(a)

    1,534       7,210  

Cara Therapeutics Inc.(a)(c)

    504       8,286  

Celldex Therapeutics Inc.(a)

    44       453  

ChemoCentryx Inc.(a)

    727       38,320  

Constellation Pharmaceuticals Inc.(a)

    391       10,514  

Cortexyme Inc.(a)

    247       9,843  

Crinetics Pharmaceuticals Inc.(a)

    482       6,690  

Cue Biopharma Inc.(a)

    576       10,892  

Cymabay Therapeutics Inc.(a)

    1,119       3,972  

CytomX Therapeutics Inc.(a)

    546       3,827  

Deciphera Pharmaceuticals Inc.(a)

    785       36,400  

Denali Therapeutics Inc.(a)

    1,517       35,528  

Dicerna Pharmaceuticals Inc.(a)

    964       20,726  

Dynavax Technologies Corp.(a)

    896       7,267  

Editas Medicine Inc.(a)

    1,059       31,092  

Emergent BioSolutions Inc.(a)

    712       79,203  

Epizyme Inc.(a)

    1,329       18,393  

Esperion Therapeutics Inc.(a)(c)

    434       16,331  

Exact Sciences Corp.(a)

    828       78,453  

Exelixis Inc.(a)

    5,317       122,770  
Security   Shares     Value  
Biotechnology (continued)  

Fate Therapeutics Inc.(a)

    1,193     $ 37,305  

FibroGen Inc.(a)

    1,288       52,125  

Five Prime Therapeutics Inc.(a)

    630       3,717  

Frequency Therapeutics Inc.(a)

    466       9,851  

Geron Corp.(a)

    1,722       2,738  

Gilead Sciences Inc.

    12,177       846,667  

GlycoMimetics Inc.(a)

    645       2,541  

Gossamer Bio Inc.(a)

    896       10,680  

Guardant Health Inc.(a)

    557       47,445  

Halozyme Therapeutics Inc.(a)

    2,228       60,579  

Homology Medicines Inc.(a)

    597       7,851  

ImmunoGen Inc.(a)

    2,658       10,924  

Immunomedics Inc.(a)

    4,059       171,412  

Incyte Corp.(a)

    1,398       138,067  

Innoviva Inc.(a)

    826       11,188  

Inovio Pharmaceuticals Inc.(a)(c)

    3,224       62,675  

Insmed Inc.(a)

    1,887       49,288  

Intercept Pharmaceuticals Inc.(a)

    475       21,679  

Ionis Pharmaceuticals Inc.(a)

    2,321       133,597  

Iovance Biotherapeutics Inc.(a)

    2,609       75,844  

Karuna Therapeutics Inc.(a)

    293       23,967  

Karyopharm Therapeutics Inc.(a)

    1,312       21,058  

Kiniksa Pharmaceuticals Ltd., Class A(a)

    388       7,574  

Kodiak Sciences Inc.(a)

    476       22,053  

Krystal Biotech Inc.(a)

    194       8,010  

Lexicon Pharmaceuticals Inc.(a)(c)

    742       1,439  

Ligand Pharmaceuticals Inc.(a)

    294       34,451  

MacroGenics Inc.(a)

    939       23,851  

MEI Pharma Inc.(a)

    2,348       6,516  

Mersana Therapeutics Inc.(a)

    1,396       27,753  

Mirati Therapeutics Inc.(a)

    706       85,645  

Moderna Inc.(a)

    5,458       404,438  

Molecular Templates Inc.(a)

    633       6,944  

Myriad Genetics Inc.(a)

    490       5,914  

Nektar Therapeutics(a)

    3,318       73,527  

NextCure Inc.(a)

    236       2,105  

Novavax Inc.(a)

    1,059       151,543  

Omeros Corp.(a)

    658       8,442  

Pieris Pharmaceuticals Inc.(a)

    896       2,303  

Precigen Inc.(a)

    616       2,593  

Prothena Corp. PLC(a)

    614       7,515  

Provention Bio Inc.(a)

    708       7,356  

PTC Therapeutics Inc.(a)

    910       42,160  

Puma Biotechnology Inc.(a)

    546       5,629  

Radius Health Inc.(a)

    700       8,785  

Regeneron Pharmaceuticals Inc.(a)

    1,540       973,388  

REGENXBIO Inc.(a)

    476       15,756  

Replimune Group Inc.(a)

    411       8,208  

Retrophin Inc.(a)

    658       13,081  

Rigel Pharmaceuticals Inc.(a)

    2,506       5,764  

Rocket Pharmaceuticals Inc.(a)(c)

    365       8,588  

Rubius Therapeutics Inc.(a)

    573       2,813  

Sage Therapeutics Inc.(a)

    1,022       46,573  

Sangamo Therapeutics Inc.(a)

    2,212       23,956  

Scholar Rock Holding Corp.(a)

    460       5,193  

Seattle Genetics Inc.(a)

    2,178       362,136  

Solid Biosciences Inc.(a)

    225       592  

Sorrento Therapeutics Inc.(a)(c)

    3,598       32,094  

Stoke Therapeutics Inc.(a)

    282       7,104  

Syndax Pharmaceuticals Inc.(a)

    673       9,496  
 

 

 

34  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Biotechnology (continued)  

Theravance Biopharma Inc.(a)

    684     $ 13,283  

Translate Bio Inc.(a)

    771       11,712  

Turning Point Therapeutics Inc.(a)

    617       36,545  

Ultragenyx Pharmaceutical Inc.(a)

    1,076       84,100  

United Therapeutics Corp.(a)

    658       73,347  

Vericel Corp.(a)

    335       5,524  

Vertex Pharmaceuticals Inc.(a)

    3,603       980,016  

Viking Therapeutics Inc.(a)

    908       6,374  

Vir Biotechnology Inc.(a)

    933       44,560  

WaVe Life Sciences Ltd.(a)

    294       2,581  

Xencor Inc.(a)

    840       25,276  

Y-mAbs Therapeutics Inc.(a)

    406       14,263  

ZIOPHARM Oncology Inc.(a)

    2,128       6,320  
   

 

 

 
      9,825,200  
Chemicals — 0.0%  

Codexis Inc.(a)

    631       7,465  
   

 

 

 
Electrical Components & Equipment — 0.2%  

Universal Display Corp.(c)

    196       34,192  
   

 

 

 
Health Care – Products — 3.2%  

10X Genomics Inc., Class A(a)

    326       32,069  

Abbott Laboratories

    296       29,789  

Adaptive Biotechnologies Corp.(a)

    878       32,767  

Axogen Inc.(a)

    196       2,229  

Baxter International Inc.

    1,427       123,264  

CareDx Inc.(a)

    240       8,004  

Cerus Corp.(a)

    2,110       15,044  

Cooper Companies Inc. (The)

    121       34,235  

Glaukos Corp.(a)

    364       15,907  

Haemonetics Corp.(a)

    182       15,954  

ICU Medical Inc.(a)

    70       12,861  

IDEXX Laboratories Inc.(a)

    48       19,092  

Inspire Medical Systems Inc.(a)

    158       15,699  

Insulet Corp.(a)

    111       22,573  

Integra LifeSciences Holdings Corp.(a)

    238       11,365  

Intersect ENT Inc.(a)

    252       4,332  

Intuitive Surgical Inc.(a)

    30       20,563  

Lantheus Holdings Inc.(a)

    726       9,786  

NanoString Technologies Inc.(a)

    248       8,955  

Natera Inc.(a)

    266       12,773  

Nevro Corp.(a)

    196       26,060  

Novocure Ltd.(a)

    935       70,864  

Penumbra Inc.(a)

    71       15,756  

Repligen Corp.(a)

    408       61,571  

ResMed Inc.

    222       44,957  

Wright Medical Group NV(a)

    432       12,969  
   

 

 

 
      679,438  
Health Care – Services — 1.4%  

Catalent Inc.(a)

    1,004       87,689  

Charles River Laboratories International Inc.(a)

    295       58,702  

IQVIA Holdings Inc.(a)

    578       91,549  

Medpace Holdings Inc.(a)

    139       16,590  

OPKO Health Inc.(a)

    3,206       16,511  

Syneos Health Inc.(a)

    392       24,457  
   

 

 

 
      295,498  
Pharmaceuticals — 47.7%  

AbbVie Inc.

    11,038       1,047,617  

Aclaris Therapeutics Inc.(a)

    476       1,023  

Adamas Pharmaceuticals Inc.(a)

    322       799  
Security   Shares     Value  
Pharmaceuticals (continued)  

Aeglea BioTherapeutics Inc.(a)

    911     $ 6,240  

Aerie Pharmaceuticals Inc.(a)

    630       7,283  

Agios Pharmaceuticals Inc.(a)

    1,132       51,302  

Aimmune Therapeutics Inc.(a)

    672       8,877  

Akcea Therapeutics Inc.(a)

    182       1,973  

Akebia Therapeutics Inc.(a)

    2,870       32,058  

Alector Inc.(a)

    1,122       17,582  

Alkermes PLC(a)

    2,353       42,378  

AmerisourceBergen Corp.

    274       27,452  

Amneal Pharmaceuticals Inc.(a)

    1,877       8,127  

Amphastar Pharmaceuticals Inc.(a)

    462       9,249  

Anika Therapeutics Inc.(a)

    140       5,096  

Antares Pharma Inc.(a)

    2,072       5,408  

Arvinas Inc.(a)

    362       11,403  

Athenex Inc.(a)(c)

    1,135       12,042  

Axsome Therapeutics Inc.(a)

    548       39,089  

Bausch Health Companies Inc.(a)(c)

    3,108       56,783  

Bioxcel Therapeutics Inc.(a)

    230       10,433  

Bristol-Myers Squibb Co.

    16,052       941,610  

Catalyst Pharmaceuticals Inc.(a)

    1,051       4,519  

Clovis Oncology Inc.(a)

    812       4,701  

Coherus Biosciences Inc.(a)

    1,077       18,944  

Collegium Pharmaceutical Inc.(a)

    378       5,965  

Concert Pharmaceuticals Inc.(a)(c)

    336       3,115  

Corbus Pharmaceuticals Holdings Inc.(a)

    784       4,916  

Corcept Therapeutics Inc.(a)

    1,540       23,023  

Cyclerion Therapeutics Inc.(a)

    210       802  

Cytokinetics Inc.(a)

    756       16,345  

DexCom Inc.(a)

    277       120,645  

Eagle Pharmaceuticals Inc./DE(a)

    196       9,092  

Eidos Therapeutics Inc.(a)

    235       9,424  

Elanco Animal Health Inc.(a)

    2,895       68,409  

Eli Lilly & Co.

    6,480       973,879  

Enanta Pharmaceuticals Inc.(a)

    238       10,912  

Endo International PLC(a)

    2,199       7,653  

Flexion Therapeutics Inc.(a)(c)

    546       7,409  

G1 Therapeutics Inc.(a)

    308       4,518  

Global Blood Therapeutics Inc.(a)(c)

    1,051       70,921  

Heron Therapeutics Inc.(a)(c)

    1,148       18,701  

Horizon Therapeutics PLC(a)

    3,224       197,277  

Intellia Therapeutics Inc.(a)(c)

    874       15,566  

Intra-Cellular Therapies Inc.(a)

    1,112       22,045  

Ironwood Pharmaceuticals Inc.(a)

    2,100       19,257  

Jazz Pharmaceuticals PLC(a)

    942       101,972  

Johnson & Johnson

    12,558       1,830,454  

Jounce Therapeutics Inc.(a)

    252       1,154  

Kadmon Holdings Inc.(a)

    3,120       11,419  

Kala Pharmaceuticals Inc.(a)

    858       7,508  

Kura Oncology Inc.(a)

    1,017       16,719  

La Jolla Pharmaceutical Co.(a)(c)

    322       1,282  

Lannett Co. Inc.(a)(c)

    406       2,416  

Madrigal Pharmaceuticals Inc.(a)

    138       14,160  

Mallinckrodt PLC(a)(c)

    614       1,369  

MediciNova Inc.(a)

    574       3,570  

Merck & Co. Inc.

    16,078       1,290,099  

Momenta Pharmaceuticals Inc.(a)

    1,905       56,178  

Mylan NV(a)(c)

    5,446       87,735  

MyoKardia Inc.(a)

    941       84,812  

Neurocrine Biosciences Inc.(a)

    1,760       211,834  

Ocular Therapeutix Inc.(a)

    1,139       8,930  
 

 

 

SCHEDULE OF INVESTMENTS

  35


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Pharmaceuticals (continued)  

Odonate Therapeutics Inc.(a)

    224     $ 8,147  

Pacira BioSciences Inc.(a)

    532       27,989  

Paratek Pharmaceuticals Inc.(a)

    434       1,897  

Perrigo Co. PLC

    1,102       58,428  

Pfizer Inc.

    29,665       1,141,509  

PRA Health Sciences Inc.(a)

    406       43,263  

Prestige Consumer Healthcare Inc.(a)

    224       8,331  

Principia Biopharma Inc.(a)

    509       42,552  

Progenics Pharmaceuticals Inc.(b)(c)

    1,001        

Protagonist Therapeutics Inc.(a)

    644       10,130  

Reata Pharmaceuticals Inc., Class A(a)(c)

    435       64,250  

Relmada Therapeutics Inc.(a)(c)

    224       8,147  

Revance Therapeutics Inc.(a)

    1,097       25,758  

Rhythm Pharmaceuticals Inc.(a)

    614       11,801  

Sarepta Therapeutics Inc.(a)

    1,353       207,713  

Spectrum Pharmaceuticals Inc.(a)

    1,638       4,898  

Supernus Pharmaceuticals Inc.(a)

    770       17,144  

Synergy Pharmaceuticals Inc.(a)(c)

    1,136       7  

Syros Pharmaceuticals Inc.(a)

    809       7,677  

TG Therapeutics Inc.(a)

    2,212       43,311  

TherapeuticsMD Inc.(a)(c)

    2,240       4,144  

Tricida Inc.(a)

    448       5,994  

UroGen Pharma Ltd.(a)

    225       4,970  

Vanda Pharmaceuticals Inc.(a)

    784       7,903  

Voyager Therapeutics Inc.(a)

    448       4,959  

Zoetis Inc.

    3,475       527,088  

Zogenix Inc.(a)

    1,008       23,980  
   

 

 

 
      10,025,463  
Telecommunications — 0.0%  

InterDigital Inc.

    126       7,562  
   

 

 

 

Total Common Stocks — 99.3%
(Cost: $19,316,190)

 

    20,874,818  
   

 

 

 

Rights

 

Pharmaceuticals — 0.1%  

Bristol-Myers Squibb Co. (Expires 3/31/2021)(a)(c)

    2,353       8,471  
   

 

 

 

Total Rights — 0.1%
(Cost: $5,012)

 

    8,471  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 2.5%  

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(d)(e)(f)

    431,550       432,025  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(d)(e)

    102,000       102,000  
   

 

 

 
      534,025  
   

 

 

 

Total Short-Term Investments — 2.5%
(Cost: $533,875)

 

    534,025  
   

 

 

 

Total Investments in Securities — 101.9%
(Cost: $19,855,077)

 

    21,417,314  

Other Assets, Less Liabilities — (1.9)%

 

    (396,308
   

 

 

 

Net Assets — 100.0%

 

  $ 21,021,006  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(c) 

All or a portion of this security is on loan.

(d) 

Affiliate of the Fund.

(e) 

Annualized 7-day yield as of period-end.

(f) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

36  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

   iShares® Evolved U.S. Innovative Healthcare ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 187,261      $ 244,685 (a)     $      $ (27    $ 106      $ 432,025        431,550      $ 3,585 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     73,000        29,000 (a)                             102,000        102,000        1,004         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ (27    $ 106      $ 534,025         $ 4,589      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 20,874,256        $        $ 562        $ 20,874,818  

Rights

     8,471                            8,471  

Money Market Funds

     534,025                            534,025  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 21,416,752        $             —        $ 562        $ 21,417,314  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS

  37


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Advertising — 0.1%  

Clear Channel Outdoor Holdings Inc.(a)

    3,072     $ 2,815  

National CineMedia Inc.

    1,687       4,167  
   

 

 

 
      6,982  
Commercial Services — 1.2%  

Graham Holdings Co., Class B

    84       33,463  

Nielsen Holdings PLC

    5,333       76,955  

Viad Corp.

    112       1,620  
   

 

 

 
      112,038  
Entertainment — 3.8%  

AMC Entertainment Holdings Inc., Class A(b)

    770       3,111  

Caesars Entertainment Inc.(a)

    370       11,488  

Churchill Downs Inc.

    301       41,695  

Cinemark Holdings Inc.

    2,177       25,754  

IMAX Corp.(a)

    1,344       15,174  

Lions Gate Entertainment Corp., Class A(a)

    2,821       21,609  

Lions Gate Entertainment Corp., Class B, NVS(a)

    5,317       37,804  

Live Nation Entertainment Inc.(a)

    1,898       88,845  

Madison Square Garden Sports Corp.(a)

    336       51,640  

Penn National Gaming Inc.(a)

    224       7,582  

Reading International Inc., Class A, NVS(a)(b)

    315       1,373  

Scientific Games Corp./DE, Class A(a)

    567       9,962  

SeaWorld Entertainment Inc.(a)

    833       12,054  

Six Flags Entertainment Corp.

    1,309       22,763  
   

 

 

 
      350,854  
Home Furnishings — 0.7%  

Dolby Laboratories Inc., Class A

    987       68,695  
   

 

 

 
Internet — 16.4%  

Alphabet Inc., Class A(a)

    57       84,813  

Alphabet Inc., Class C, NVS(a)

    58       86,012  

IAC/InterActiveCorp.(a)

    993       131,493  

Match Group Inc(a)(b)

    2,143       220,086  

Netflix Inc.(a)

    837       409,193  

Roku Inc.(a)

    2,062       319,383  

Twitter Inc.(a)

    7,281       265,028  
   

 

 

 
      1,516,008  
Leisure Time — 0.1%  

Carnival Corp.

    330       4,580  

Liberty TripAdvisor Holdings Inc., Class A(a)

    610       1,513  
   

 

 

 
      6,093  
Lodging — 0.2%  

Las Vegas Sands Corp.

    343       14,969  

Marcus Corp. (The)

    210       2,900  
   

 

 

 
      17,869  
Media — 57.1%  

Altice USA Inc., Class A(a)

    7,401       199,753  

AMC Networks Inc., Class A(a)

    1,512       34,928  

Cable One Inc.(b)

    114       207,772  

Central European Media Enterprises Ltd., Class A(a)

    2,767       11,013  

Charter Communications Inc., Class A(a)(b)

    796       461,680  

Comcast Corp., Class A

    11,178       478,418  

Discovery Inc., Class A(a)

    5,669       119,616  

Discovery Inc., Class C, NVS(a)

    12,597       238,713  

DISH Network Corp., Class A(a)

    6,264       201,137  

Entercom Communications Corp., Class A

    4,634       6,488  

Entravision Communications Corp., Class A

    1,062       1,402  

EW Scripps Co. (The), Class A, NVS

    2,886       32,843  
Security   Shares     Value  
Media (continued)  

Fox Corp., Class A, NVS

    11,887     $ 306,328  

Fox Corp., Class B(a)

    7,812       201,315  

Gannett Co. Inc.

    1,518       2,247  

Gray Television Inc.(a)

    4,016       57,589  

Hemisphere Media Group Inc.(a)

    721       6,345  

Iheartmedia Inc., Class A(a)

    813       6,797  

John Wiley & Sons Inc., Class A

    356       12,043  

Liberty Broadband Corp., Class A(a)

    536       72,365  

Liberty Broadband Corp., Class C, NVS(a)

    2,799       384,219  

Liberty Global PLC, Class A(a)

    2,177       50,953  

Liberty Global PLC, Class C, NVS(a)

    6,608       150,398  

Liberty Latin America Ltd., Class A(a)

    271       2,786  

Liberty Latin America Ltd., Class C, NVS(a)

    1,279       13,084  

Liberty Media Corp.-Liberty SiriusXM, Class A(a)

    504       17,534  

Liberty Media Corp.-Liberty SiriusXM, Class C, NVS(a)

    578       20,224  

Madison Square Garden Entertainment Corp.(a)

    100       7,086  

Meredith Corp.

    1,330       19,099  

MSG Networks Inc., Class A(a)

    1,841       17,545  

New York Times Co. (The), Class A

    3,696       170,533  

News Corp., Class A, NVS

    9,687       123,219  

News Corp., Class B

    3,024       38,586  

Nexstar Media Group Inc., Class A

    2,132       186,870  

Saga Communications Inc., Class A

    189       4,419  

Scholastic Corp., NVS

    378       9,045  

Sinclair Broadcast Group Inc., Class A

    2,540       52,324  

Sirius XM Holdings Inc.

    26,405       155,261  

TEGNA Inc.

    10,295       121,275  

ViacomCBS Inc., Class A

    230       6,380  

ViacomCBS Inc., Class B, NVS

    20,011       521,686  

Walt Disney Co. (The)

    3,765       440,279  

World Wrestling Entertainment Inc., Class A

    1,906       88,839  
   

 

 

 
      5,260,436  
Real Estate Investment Trusts — 0.8%  

Lamar Advertising Co., Class A

    805       52,913  

Ryman Hospitality Properties Inc.

    562       17,995  
   

 

 

 
      70,908  
Retail — 1.1%  

Qurate Retail Inc. Series A(a)

    9,461       103,220  
   

 

 

 
Software — 13.6%  

Activision Blizzard Inc.

    5,054       417,612  

Daily Journal Corp.(a)

    14       3,976  

Electronic Arts Inc.(a)(b)

    3,108       440,155  

Glu Mobile Inc.(a)

    1,407       13,282  

Take-Two Interactive Software Inc.(a)

    1,667       273,421  

Xperi Holding Corp.

    1,041       19,196  

Zynga Inc., Class A(a)

    8,731       85,826  
   

 

 

 
      1,253,468  
Telecommunications — 1.3%  

AT&T Inc.

    1,378       40,761  

GCI Liberty Inc., Class A(a)

    630       49,386  

Harmonic Inc.(a)

    812       4,531  

Shenandoah Telecommunications Co.

    527       26,492  
   

 

 

 
      121,170  
Toys, Games & Hobbies — 2.7%  

Hasbro Inc.

    2,868       208,676  
 

 

 

38  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Toys, Games & Hobbies (continued)            

Mattel Inc.(a)

    3,200     $ 35,552  
   

 

 

 
      244,228  
   

 

 

 

Total Common Stocks — 99.1%
(Cost: $8,650,260)

 

    9,131,969  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 6.3%            

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    507,245       507,804  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    78,000       78,000  
   

 

 

 
      585,804  
   

 

 

 

Total Short-Term Investments — 6.3%
(Cost: $585,838)

 

    585,804  
   

 

 

 

Total Investments in Securities — 105.4%
(Cost: $9,236,098)

 

    9,717,773  

Other Assets, Less Liabilities — (5.4)%

 

    (499,282
   

 

 

 

Net Assets — 100.0%

 

  $ 9,218,491  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 87,140      $ 420,614 (a)     $      $ 94      $ (44    $ 507,804        507,245      $ 2,229 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     51,000        27,000 (a)                             78,000        78,000        703         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ 94      $ (44    $ 585,804         $ 2,932      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 9,131,969        $             —        $             —        $ 9,131,969  

Money Market Funds

     585,804                            585,804  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 9,717,773        $        $        $ 9,717,773  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS

  39


Schedule of Investments

July 31, 2020

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Advertising — 0.3%  

Interpublic Group of Companies Inc. (The)

    2,296     $ 41,443  

Omnicom Group Inc.

    1,131       60,768  

Trade Desk Inc. (The), Class A(a)

    315       142,166  
   

 

 

 
      244,377  
Aerospace & Defense — 0.0%  

L3Harris Technologies Inc.

    229       38,548  
   

 

 

 
Banks — 0.2%  

JPMorgan Chase & Co.

    1,415       136,746  
   

 

 

 
Biotechnology — 0.0%  

Incyte Corp.(a)

    401       39,603  
   

 

 

 
Commercial Services — 4.7%  

2U Inc.(a)(b)

    273       12,857  

Automatic Data Processing Inc.

    2,454       326,161  

Avalara Inc.(a)

    508       68,301  

Booz Allen Hamilton Holding Corp.

    511       41,779  

Chegg Inc.(a)

    1,050       85,019  

CoreLogic Inc.

    351       23,924  

CoStar Group Inc.(a)

    156       132,563  

Equifax Inc.

    546       88,758  

FleetCor Technologies Inc.(a)

    390       100,842  

Gartner Inc.(a)

    624       77,775  

Global Payments Inc.

    1,284       228,578  

IHS Markit Ltd.

    1,756       141,762  

Korn Ferry

    312       8,767  

LiveRamp Holdings Inc.(a)

    52       2,370  

MarketAxess Holdings Inc.

    117       60,454  

Moody’s Corp.

    507       142,619  

Nielsen Holdings PLC

    1,324       19,105  

Paylocity Holding Corp.(a)

    385       51,282  

PayPal Holdings Inc.(a)

    6,635       1,300,924  

Robert Half International Inc.

    429       21,823  

S&P Global Inc.

    936       327,834  

Sabre Corp.

    1,209       9,140  

Square Inc., Class A(a)

    2,105       273,334  

TransUnion

    936       83,838  

Verisk Analytics Inc.

    585       110,395  

WEX Inc.(a)

    156       24,706  
   

 

 

 
      3,764,910  
Computers — 16.5%  

Accenture PLC, Class A

    3,979       894,400  

Apple Inc.

    22,743       9,666,685  

CACI International Inc., Class A(a)

    117       24,315  

Cognizant Technology Solutions Corp., Class A

    3,747       255,995  

Crowdstrike Holdings Inc., Class A(a)

    1,989       225,155  

Dell Technologies Inc., Class C(a)

    1,560       93,335  

DXC Technology Co.

    2,184       39,115  

EPAM Systems Inc.(a)

    312       90,505  

Fortinet Inc.(a)

    1,248       172,598  

Genpact Ltd.

    897       35,719  

Hewlett Packard Enterprise Co.

    9,830       97,022  

HP Inc.

    6,429       113,022  

International Business Machines Corp.

    7,287       895,864  

Lumentum Holdings Inc.(a)

    234       21,722  

NCR Corp.(a)

    624       11,500  

NetApp Inc.

    2,108       93,384  

Pure Storage Inc., Class A(a)

    858       15,324  
Security   Shares     Value  
Computers (continued)  

Qualys Inc.(a)

    312     $ 38,526  

Rapid7 Inc.(a)

    511       30,440  

Seagate Technology PLC

    1,404       63,489  

Western Digital Corp.

    1,872       80,683  

Zscaler Inc.(a)

    742       96,349  
   

 

 

 
      13,055,147  
Distribution & Wholesale — 0.1%  

Copart Inc.(a)

    468       43,641  

KAR Auction Services Inc.

    351       5,311  
   

 

 

 
      48,952  
Diversified Financial Services — 5.1%  

Cboe Global Markets Inc.

    390       34,203  

CME Group Inc.

    1,326       220,355  

Discover Financial Services

    312       15,422  

Interactive Brokers Group Inc., Class A

    234       11,606  

Intercontinental Exchange Inc.

    2,262       218,916  

Invesco Ltd.

    860       8,634  

Mastercard Inc., Class A

    4,871       1,502,850  

Nasdaq Inc.

    429       56,332  

SEI Investments Co.

    468       24,491  

Visa Inc., Class A

    9,980       1,900,192  

Western Union Co. (The)

    1,521       36,930  
   

 

 

 
      4,029,931  
Electronics — 0.4%  

Agilent Technologies Inc.

    622       59,917  

Allegion PLC

    239       23,771  

Coherent Inc.(a)

    78       10,829  

Garmin Ltd.

    352       34,704  

Keysight Technologies Inc.(a)

    819       81,810  

National Instruments Corp.

    741       26,306  

Roper Technologies Inc.

    116       50,164  

SYNNEX Corp.

    156       19,459  

Trimble Inc.(a)

    1,014       45,133  
   

 

 

 
      352,093  
Energy – Alternate Sources — 0.1%  

Enphase Energy Inc.(a)

    788       47,564  
   

 

 

 
Health Care – Products — 0.1%  

Align Technology Inc.(a)

    244       71,692  
   

 

 

 
Health Care – Services — 0.2%  

IQVIA Holdings Inc.(a)

    429       67,950  

Teladoc Health Inc.(a)

    356       84,596  
   

 

 

 
      152,546  
Insurance — 0.4%  

Aon PLC, Class A

    595       122,106  

Marsh & McLennan Companies Inc.

    1,053       122,780  

Willis Towers Watson PLC

    346       72,663  
   

 

 

 
      317,549  
Internet — 26.2%  

Alphabet Inc., Class A(a)

    2,151       3,200,580  

Alphabet Inc., Class C, NVS(a)

    2,071       3,071,210  

Amazon.com Inc.(a)

    2,145       6,788,239  

Anaplan Inc.(a)

    1,048       47,590  

Booking Holdings Inc.(a)

    160       265,941  

CDW Corp./DE

    858       99,743  

eBay Inc.

    4,677       258,545  

Etsy Inc.(a)

    389       46,050  

Expedia Group Inc.

    507       41,072  
 

 

 

40  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Internet (continued)  

F5 Networks Inc.(a)

    507     $ 68,901  

Facebook Inc., Class A(a)

    17,002       4,312,897  

FireEye Inc.(a)

    1,209       18,256  

GoDaddy Inc., Class A(a)

    897       63,041  

Grubhub Inc.(a)

    351       25,356  

IAC/InterActiveCorp.(a)

    351       46,479  

Match Group Inc(a)

    1,198       123,035  

MercadoLibre Inc.(a)

    234       263,161  

Netflix Inc.(a)

    1,136       555,368  

NortonLifeLock Inc.

    3,859       82,776  

Okta Inc.(a)

    1,091       241,089  

Palo Alto Networks Inc.(a)

    780       199,618  

Pinterest Inc., Class A(a)

    822       28,186  

Proofpoint Inc.(a)

    429       49,622  

Q2 Holdings Inc.(a)

    388       36,491  

Roku Inc.(a)

    586       90,766  

Snap Inc., Class A, NVS(a)(b)

    6,634       148,734  

TD Ameritrade Holding Corp.

    819       29,394  

Twitter Inc.(a)

    4,486       163,290  

Uber Technologies Inc.(a)

    6,656       201,411  

VeriSign Inc.(a)

    698       147,753  

Zendesk Inc.(a)

    663       60,432  

Zillow Group Inc., Class C, NVS(a)

    546       37,341  
   

 

 

 
      20,812,367  
Leisure Time — 0.1%  

Peloton Interactive Inc., Class A(a)

    1,219       83,160  
   

 

 

 
Machinery — 0.1%  

Cognex Corp.

    780       52,158  

Rockwell Automation Inc.

    156       34,030  
   

 

 

 
      86,188  
Media — 0.1%  

FactSet Research Systems Inc.

    195       67,528  
   

 

 

 
Office & Business Equipment — 0.1%  

Zebra Technologies Corp., Class A(a)

    312       87,594  
   

 

 

 
Pharmaceuticals — 0.1%  

Zoetis Inc.

    311       47,172  
   

 

 

 
Private Equity — 0.1%  

Blackstone Group Inc. (The), Class A

    1,326       70,649  
   

 

 

 
Real Estate — 0.1%  

CBRE Group Inc., Class A(a)

    814       35,661  

Jones Lang LaSalle Inc.

    156       15,430  
   

 

 

 
      51,091  
Real Estate Investment Trusts — 0.3%  

Digital Realty Trust Inc.

    738       118,478  

Equinix Inc.

    160       125,677  

Iron Mountain Inc.

    1,053       29,684  
   

 

 

 
      273,839  
Retail — 0.1%  

Best Buy Co. Inc.

    546       54,376  
   

 

 

 
Semiconductors — 9.1%  

Advanced Micro Devices Inc.(a)

    7,451       576,931  

Analog Devices Inc.

    1,443       165,729  

Applied Materials Inc.

    3,363       216,342  

Broadcom Inc.

    1,984       628,432  

Inphi Corp.(a)

    385       50,304  
Security   Shares     Value  
Semiconductors (continued)  

Intel Corp.

    17,797     $ 849,451  

KLA Corp.

    663       132,487  

Lam Research Corp.

    554       208,947  

Marvell Technology Group Ltd.

    4,761       173,634  

Maxim Integrated Products Inc.

    1,599       108,876  

Microchip Technology Inc.

    1,248       126,959  

Micron Technology Inc.(a)

    5,975       299,079  

Monolithic Power Systems Inc.

    234       62,012  

NVIDIA Corp.

    4,800       2,038,032  

ON Semiconductor Corp.(a)

    2,105       43,363  

Qorvo Inc.(a)

    588       75,352  

Qualcomm Inc.

    5,413       571,667  

Silicon Laboratories Inc.(a)

    273       27,439  

Skyworks Solutions Inc.

    863       125,635  

Teradyne Inc.

    892       79,352  

Texas Instruments Inc.

    3,985       508,287  

Xilinx Inc.

    1,638       175,839  
   

 

 

 
      7,244,149  
Software — 32.4%  

ACI Worldwide Inc.(a)

    780       20,896  

Activision Blizzard Inc.

    2,769       228,802  

Adobe Inc.(a)

    3,747       1,664,867  

Akamai Technologies Inc.(a)

    1,170       131,555  

Alteryx Inc., Class A(a)

    586       102,837  

ANSYS Inc.(a)

    546       169,588  

Aspen Technology Inc.(a)

    390       37,931  

Autodesk Inc.(a)

    1,635       386,563  

Black Knight Inc.(a)

    546       40,906  

Blackbaud Inc.

    351       21,952  

Blackline Inc.(a)

    624       55,480  

Box Inc., Class A(a)

    1,053       18,901  

Broadridge Financial Solutions Inc.

    546       73,350  

Cadence Design Systems Inc.(a)

    1,911       208,777  

CDK Global Inc.

    741       33,686  

Ceridian HCM Holding Inc.(a)

    1,091       85,414  

Cerner Corp.

    1,131       78,548  

Citrix Systems Inc.

    1,092       155,894  

Cloudera Inc.(a)

    897       10,109  

CommVault Systems Inc.(a)

    351       15,472  

Cornerstone OnDemand Inc.(a)

    468       16,619  

Coupa Software Inc.(a)

    624       191,225  

Datadog Inc., Class A(a)

    1,957       183,684  

DocuSign Inc.(a)

    1,523       330,232  

Dropbox Inc., Class A(a)

    2,337       53,167  

Dynatrace Inc.(a)

    1,763       73,746  

Elastic NV(a)

    507       48,768  

Electronic Arts Inc.(a)

    1,443       204,358  

Everbridge Inc.(a)

    352       50,266  

Fair Isaac Corp.(a)

    195       85,642  

Fidelity National Information Services Inc.

    2,849       416,837  

Fiserv Inc.(a)

    3,381       337,390  

Five9 Inc.(a)

    583       70,438  

Guidewire Software Inc.(a)

    507       59,654  

HubSpot Inc.(a)

    273       64,049  

Intuit Inc.

    1,560       477,937  

j2 Global Inc.(a)

    273       15,485  

Jack Henry & Associates Inc.

    468       83,444  

Manhattan Associates Inc.(a)

    507       48,566  

Microsoft Corp.

    63,684       13,055,857  

MongoDB Inc.(a)(b)

    388       88,883  
 

 

 

SCHEDULE OF INVESTMENTS

  41


Schedule of Investments  (continued)

July 31, 2020

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Software (continued)  

MSCI Inc.

    468     $ 175,959  

New Relic Inc.(a)

    351       24,889  

Nuance Communications Inc.(a)

    594       16,246  

Nutanix Inc., Class A(a)

    1,753       38,899  

Oracle Corp.

    19,000       1,053,550  

Paychex Inc.

    1,792       128,881  

Paycom Software Inc.(a)

    351       99,814  

Pegasystems Inc.

    312       36,470  

PTC Inc.(a)

    936       80,084  

RealPage Inc.(a)

    351       22,116  

RingCentral Inc., Class A(a)

    429       124,526  

salesforce.com Inc.(a)

    7,748       1,509,698  

ServiceNow Inc.(a)

    1,642       721,166  

Slack Technologies Inc., Class A(a)(b)

    4,991       147,484  

Smartsheet Inc., Class A(a)

    1,174       56,047  

Splunk Inc.(a)

    1,448       303,819  

SS&C Technologies Holdings Inc.

    1,014       58,305  

Synopsys Inc.(a)

    1,092       217,548  

Take-Two Interactive Software Inc.(a)

    469       76,925  

Twilio Inc., Class A(a)

    1,089       302,110  

Tyler Technologies Inc.(a)

    234       83,596  

Veeva Systems Inc., Class A(a)

    1,042       275,682  

Verint Systems Inc.(a)

    468       21,009  

VMware Inc., Class A(a)

    624       87,491  

Workday Inc., Class A(a)

    1,484       268,485  

Zoom Video Communications Inc., Class A(a)

    869       220,648  

Zynga Inc., Class A(a)

    4,251       41,787  
   

 

 

 
      25,691,009  
Telecommunications — 2.4%  

Arista Networks Inc.(a)

    468       121,572  

Ciena Corp.(a)

    936       55,701  

Cisco Systems Inc.

    32,455       1,528,631  

CommScope Holding Co. Inc.(a)

    624       5,791  

Juniper Networks Inc.

    2,769       70,277  
Security   Shares     Value  
Telecommunications (continued)  

LogMeIn Inc.

    390     $ 33,466  

Motorola Solutions Inc.

    624       87,235  
   

 

 

 
      1,902,673  
Transportation — 0.1%  

Expeditors International of Washington Inc.

    507       42,847  

FedEx Corp.

    355       59,782  
   

 

 

 
      102,629  
   

 

 

 

Total Common Stocks — 99.4%
(Cost: $64,338,184)

 

    78,874,082  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.7%  

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

0.40%(c)(d)(e)

    77,963       78,048  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

0.12%(c)(d)

    480,000       480,000  
   

 

 

 
      558,048  
   

 

 

 

Total Short-Term Investments — 0.7%
(Cost: $557,914)

      558,048  
   

 

 

 

Total Investments in Securities — 100.1%
(Cost: $64,896,098)

      79,432,130  

Other Assets, Less Liabilities — (0.1)%

      (76,711
   

 

 

 

Net Assets — 100.0%

    $ 79,355,419  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended July 31, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/19
     Purchases
at Cost
     Proceeds
from Sales
     Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
07/31/20
     Shares
Held at
07/31/20
     Income      Capital Gain
Distributions from
Underlying Funds
 

BlackRock Cash Funds: Institutional,
SL Agency Shares

   $ 149,637      $      $ (71,496 )(a)     $ (218    $ 125      $ 78,048        77,963      $ 2,638 (b)     $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     188,000        292,000 (a)                            480,000        480,000        1,630         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ (218    $ 125      $ 558,048         $ 4,268      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

42  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2020

   iShares® Evolved U.S. Technology ETF

 

Fair Value Measurements (continued)

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                 

Assets

                 

Common Stocks

   $ 78,874,082        $        $        $ 78,874,082  

Money Market Funds

     558,048                            558,048  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 79,432,130        $             —        $             —        $ 79,432,130  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS

  43


 

Statements of Assets and Liabilities

July 31, 2020

 

     iShares
Evolved
U.S. Consumer
Staples ETF
     iShares
Evolved
U.S. Discretionary
Spending ETF
     iShares
Evolved
U.S. Financials
ETF
    iShares
Evolved
U.S. Healthcare
Staples ETF
 

ASSETS

         

Investments in securities, at value (including securities on loan)(a):

         

Unaffiliated(b)

  $ 9,783,351      $ 11,924,903      $ 4,077,980     $ 14,922,849  

Affiliated(c)

    228,457        49,972        38,503       294,052  

Cash

    114        6,680        2,308       7,545  

Receivables:

         

Securities lending income — Affiliated

    60        95        4       106  

Dividends

    11,187        5,282        5,230       12,041  
 

 

 

    

 

 

    

 

 

   

 

 

 

Total assets

    10,023,169        11,986,932        4,124,025       15,236,593  
 

 

 

    

 

 

    

 

 

   

 

 

 

LIABILITIES

         

Collateral on securities loaned, at value

    162,361        4,632        8,508       227,733  

Payables:

         

Investment advisory fees

    1,457        1,764        620       2,208  
 

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities

    163,818        6,396        9,128       229,941  
 

 

 

    

 

 

    

 

 

   

 

 

 

NET ASSETS

  $ 9,859,351      $ 11,980,536      $ 4,114,897     $ 15,006,652  
 

 

 

    

 

 

    

 

 

   

 

 

 

NET ASSETS CONSIST OF:

         

Paid-in capital

  $ 9,064,293      $ 10,447,563      $ 4,938,160     $ 12,757,940  

Accumulated earnings (loss)

    795,058        1,532,973        (823,263     2,248,712  
 

 

 

    

 

 

    

 

 

   

 

 

 

NET ASSETS

  $ 9,859,351      $ 11,980,536      $ 4,114,897     $ 15,006,652  
 

 

 

    

 

 

    

 

 

   

 

 

 

Shares outstanding

    350,000        350,000        200,000       450,000  
 

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value

  $ 28.17      $ 34.23      $ 20.57     $ 33.35  
 

 

 

    

 

 

    

 

 

   

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited       Unlimited  
 

 

 

    

 

 

    

 

 

   

 

 

 

Par value

    None        None        None       None  
 

 

 

    

 

 

    

 

 

   

 

 

 

(a) Securities loaned, at value

  $ 159,833      $ 4,382      $ 8,416     $ 222,347  

(b) Investments, at cost — Unaffiliated

  $ 8,963,850      $ 10,336,966      $ 4,879,934     $ 12,675,936  

(c) Investments, at cost — Affiliated

  $ 228,312      $ 49,963      $ 38,504     $ 294,045  

See notes to financial statements.

 

 

44  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


 

Statements of Assets and Liabilities  (continued)

July 31, 2020

 

     iShares
Evolved
U.S. Innovative
Healthcare
ETF
     iShares
Evolved
U.S. Media and
Entertainment
ETF
     iShares
Evolved
U.S. Technology
ETF
 

ASSETS

       

Investments in securities, at value (including securities on loan)(a):

       

Unaffiliated(b)

  $ 20,883,289      $ 9,131,969      $ 78,874,082  

Affiliated(c)

    534,025        585,804        558,048  

Cash

    6,949        6,690        984  

Receivables:

       

Securities lending income — Affiliated

    851        307        156  

Dividends

    30,835        2,800        11,156  
 

 

 

    

 

 

    

 

 

 

Total assets

    21,455,949        9,727,570        79,444,426  
 

 

 

    

 

 

    

 

 

 

LIABILITIES

       

Collateral on securities loaned, at value

    431,884        507,715        78,125  

Payables:

       

Investment advisory fees

    3,059        1,364        10,882  
 

 

 

    

 

 

    

 

 

 

Total liabilities

    434,943        509,079        89,007  
 

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 21,021,006      $ 9,218,491      $ 79,355,419  
 

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF:

       

Paid-in capital

  $ 19,317,037      $ 8,725,668      $ 64,832,783  

Accumulated earnings

    1,703,969        492,823        14,522,636  
 

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 21,021,006      $ 9,218,491      $ 79,355,419  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    700,000        350,000        1,950,000  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 30.03      $ 26.34      $ 40.70  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

    None        None        None  
 

 

 

    

 

 

    

 

 

 

(a) Securities loaned, at value

  $ 402,847      $ 506,387      $ 77,410  

(b) Investments, at cost — Unaffiliated

  $ 19,321,202      $ 8,650,260      $ 64,338,184  

(c) Investments, at cost — Affiliated

  $ 533,875      $ 585,838      $ 557,914  

See notes to financial statements.

 

 

FINANCIAL STATEMENTS

  45


 

Statements of Operations

Year Ended July 31, 2020

 

     iShares
Evolved
U.S. Consumer
Staples ETF
    iShares
Evolved
U.S. Discretionary
Spending ETF
    iShares
Evolved
U.S. Financials
ETF
    iShares
Evolved
U.S. Healthcare
Staples ETF
 

INVESTMENT INCOME

       

Dividends — Unaffiliated

  $ 229,434     $ 134,799     $ 120,986     $ 126,694  

Dividends — Affiliated

    557       932       331       715  

Securities lending income — Affiliated — net

    1,314       991       91       1,094  

Foreign taxes withheld

                (36      
 

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

    231,305       136,722       121,372       128,503  
 

 

 

   

 

 

   

 

 

   

 

 

 

EXPENSES

       

Investment advisory fees

    15,050       18,298       8,234       19,178  

Miscellaneous

    264             264       264  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

    15,314       18,298       8,498       19,442  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    215,991       118,424       112,874       109,061  
 

 

 

   

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

       

Net realized gain (loss) from:

       

Investments — Unaffiliated

    (50,963     (27,830     13,348       (12,014

Investments — Affiliated

    (47     298       61       310  

In-kind redemptions — Unaffiliated

          1,012,528             205,296  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

    (51,010     984,996       13,409       193,592  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

       

Investments — Unaffiliated

    392,573       673,477       (870,281     1,465,763  

Investments — Affiliated

    145       6       (1     1  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    392,718       673,483       (870,282     1,465,764  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

    341,708       1,658,479       (856,873     1,659,356  
 

 

 

   

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $ 557,699     $ 1,776,903     $ (743,999   $ 1,768,417  
 

 

 

   

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

46  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


 

Statements of Operations  (continued)

Year Ended July 31, 2020

 

     iShares
Evolved
U.S. Innovative
Healthcare
ETF
    iShares
Evolved
U.S. Media and
Entertainment
ETF
    iShares
Evolved
U.S. Technology
ETF
 

INVESTMENT INCOME

     

Dividends — Unaffiliated

  $ 144,885     $ 61,425     $ 261,742  

Dividends — Affiliated

    1,004       703       1,630  

Securities lending income — Affiliated — net

    3,585       2,229       2,638  
 

 

 

   

 

 

   

 

 

 

Total investment income

    149,474       64,357       266,010  
 

 

 

   

 

 

   

 

 

 

EXPENSES

     

Investment advisory fees

    15,780       11,888       53,157  

Miscellaneous

          264       264  
 

 

 

   

 

 

   

 

 

 

Total expenses

    15,780       12,152       53,421  
 

 

 

   

 

 

   

 

 

 

Net investment income

    133,694       52,205       212,589  
 

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain (loss) from:

     

Investments — Unaffiliated

    124,588       9,382       (30,145

Investments — Affiliated

    (27     94       (218

In-kind redemptions — Unaffiliated

          210,212        
 

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

    124,561       219,688       (30,363
 

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

     

Investments — Unaffiliated

    1,615,384       (45,153     13,159,894  

Investments — Affiliated

    106       (44     125  
 

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    1,615,490       (45,197     13,160,019  
 

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain

    1,740,051       174,491       13,129,656  
 

 

 

   

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 1,873,745     $ 226,696     $ 13,342,245  
 

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

FINANCIAL STATEMENTS

  47


 

Statements of Changes in Net Assets

 

    iShares Evolved U.S.
Consumer Staples ETF
          iShares Evolved U.S.
Discretionary Spending ETF
 
     Year Ended
07/31/20
    Year Ended
07/31/19
           Year Ended
07/31/20
    Year Ended
07/31/19
 

INCREASE (DECREASE) IN NET ASSETS

         

OPERATIONS

         

Net investment income

  $ 215,991     $ 98,934       $ 118,424     $ 78,181  

Net realized gain (loss)

    (51,010     8,811         984,996       33,880  

Net change in unrealized appreciation (depreciation)

    392,718       409,474         673,483       506,932  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net increase in net assets resulting from operations

    557,699       517,219         1,776,903       618,993  
 

 

 

   

 

 

     

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

         

Decrease in net assets resulting from distributions to shareholders

    (191,747     (135,321       (168,954     (92,875
 

 

 

   

 

 

     

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

         

Net increase in net assets derived from capital share transactions

    5,356,261               4,477,589        
 

 

 

   

 

 

     

 

 

   

 

 

 

NET ASSETS

         

Total increase in net assets

    5,722,213       381,898         6,085,538       526,118  

Beginning of period

    4,137,138       3,755,240         5,894,998       5,368,880  
 

 

 

   

 

 

     

 

 

   

 

 

 

End of period

  $ 9,859,351     $ 4,137,138       $ 11,980,536     $ 5,894,998  
 

 

 

   

 

 

     

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

48  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


 

Statements of Changes in Net Assets  (continued)

 

    iShares Evolved U.S.
Financials ETF
          iShares Evolved U.S.
Healthcare Staples ETF
 
     Year Ended
07/31/20
    Year Ended
07/31/19
           Year Ended
07/31/20
    Year Ended
07/31/19
 

INCREASE (DECREASE) IN NET ASSETS

         

OPERATIONS

         

Net investment income

  $ 112,874     $ 100,542       $ 109,061     $ 52,022  

Net realized gain (loss)

    13,409       (20,809       193,592       210,303  

Net change in unrealized appreciation (depreciation)

    (870,282     72,632         1,465,764       251,235  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (743,999     152,365         1,768,417       513,560  
 

 

 

   

 

 

     

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

         

Decrease in net assets resulting from distributions to shareholders

    (112,279     (100,143       (158,642     (80,138
 

 

 

   

 

 

     

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

         

Net increase in net assets derived from capital share transactions

                  6,032,352       1,435,729  
 

 

 

   

 

 

     

 

 

   

 

 

 

NET ASSETS

         

Total increase (decrease) in net assets

    (856,278     52,222         7,642,127       1,869,151  

Beginning of period

    4,971,175       4,918,953         7,364,525       5,495,374  
 

 

 

   

 

 

     

 

 

   

 

 

 

End of period

  $ 4,114,897     $ 4,971,175       $ 15,006,652     $ 7,364,525  
 

 

 

   

 

 

     

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

FINANCIAL STATEMENTS

  49


 

Statements of Changes in Net Assets  (continued)

 

    iShares Evolved U.S.
Innovative Healthcare ETF
           iShares Evolved U.S. Media
and Entertainment ETF
 
     Year Ended
07/31/20
    Year Ended
07/31/19
            Year Ended
07/31/20
    Year Ended
07/31/19
 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 133,694     $ 73,830        $ 52,205     $ 54,799  

Net realized gain

    124,561       78,944          219,688       208,253  

Net change in unrealized appreciation (depreciation)

    1,615,490       (309,456        (45,197     249,943  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    1,873,745       (156,682        226,696       512,995  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Decrease in net assets resulting from distributions to shareholders

    (200,327     (100,052        (251,996     (81,138
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase in net assets derived from capital share transactions

    14,398,781                2,187,965       1,347,171  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase (decrease) in net assets

    16,072,199       (256,734        2,162,665       1,779,028  

Beginning of period

    4,948,807       5,205,541          7,055,826       5,276,798  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of period

  $ 21,021,006     $ 4,948,807        $ 9,218,491     $ 7,055,826  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

50  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


 

Statements of Changes in Net Assets  (continued)

 

    iShares Evolved U.S.
Technology ETF
 
     Year Ended
07/31/20
    Year Ended
07/31/19
 

INCREASE (DECREASE) IN NET ASSETS

   

OPERATIONS

   

Net investment income

  $ 212,589     $ 56,561  

Net realized gain (loss)

    (30,363     40,935  

Net change in unrealized appreciation (depreciation)

    13,160,019       1,019,560  
 

 

 

   

 

 

 

Net increase in net assets resulting from operations

    13,342,245       1,117,056  
 

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

   

Decrease in net assets resulting from distributions to shareholders

    (220,597     (74,296
 

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

   

Net increase in net assets derived from capital share transactions

    49,763,348       10,161,391  
 

 

 

   

 

 

 

NET ASSETS

   

Total increase in net assets

    62,884,996       11,204,151  

Beginning of period

    16,470,423       5,266,272  
 

 

 

   

 

 

 

End of period

  $ 79,355,419     $ 16,470,423  
 

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

 

FINANCIAL STATEMENTS

  51


Financial Highlights

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Consumer Staples ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 27.58      $ 25.03      $ 24.62  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.70        0.66        0.31 (c)  

Net realized and unrealized gain(d)

    0.51        2.80        0.26  
 

 

 

    

 

 

    

 

 

 

Net increase from investment operations

    1.21        3.46        0.57  
 

 

 

    

 

 

    

 

 

 

Distributions(e)

       

From net investment income

    (0.62      (0.85      (0.16

From net realized gain

           (0.06       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.62      (0.91      (0.16
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 28.17      $ 27.58      $ 25.03  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    4.56      14.23      2.34 %(f) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(g) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    2.58      2.59      3.58 %(c)(g) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 9,859      $ 4,137      $ 3,755  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(h)

    13      9      0 %(f)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Includes a special distribution from Dr Pepper Snapple Group Inc. Excluding such special distribution, the net investment income would have been $0.21 per share and 2.39% of average net assets.

(d) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(e) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(f) 

Not annualized.

(g) 

Annualized.

(h) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

52  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Discretionary Spending ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 29.47      $ 26.84      $ 24.95  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.35        0.39        0.12  

Net realized and unrealized gain(c)

    4.90        2.70        1.86  
 

 

 

    

 

 

    

 

 

 

Net increase from investment operations

    5.25        3.09        1.98  
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.33      (0.41      (0.09

From net realized gain

    (0.16      (0.05       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.49      (0.46      (0.09
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 34.23      $ 29.47      $ 26.84  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    18.11      11.73      7.96 %(e) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(f) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    1.16      1.42      1.25 %(f) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 11,981      $ 5,895      $ 5,369  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(g)

    10      11      0 %(e)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS

  53


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Financials ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 24.86      $ 24.59      $ 24.98  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.56        0.50        0.15  

Net realized and unrealized gain (loss)(c)

    (4.29      0.27        (0.43
 

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    (3.73      0.77        (0.28
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.56      (0.50      (0.11
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.56      (0.50      (0.11
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 20.57      $ 24.86      $ 24.59  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    (15.10 )%       3.35      (1.11 )%(e)(f) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.19      0.18      0.18 %(g) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    2.47      2.15      1.65 %(g) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 4,115      $ 4,971      $ 4,919  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(h)

    8      10      13 %(e)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Includes payment received from an affiliate, which impacted the Fund’s total return. Excluding the payment from an affiliate, the Fund’s total return would have been -1.40%.

(g) 

Annualized.

(h) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

54  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Healthcare Staples ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 29.46      $ 27.48      $ 24.86  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.31        0.27        0.08  

Net realized and unrealized gain(c)

    4.07        2.11        2.60  
 

 

 

    

 

 

    

 

 

 

Net increase from investment operations

    4.38        2.38        2.68  
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.25      (0.28      (0.06

From net realized gain

    (0.24      (0.12       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.49      (0.40      (0.06
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 33.35      $ 29.46      $ 27.48  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    15.04      8.77      10.77 %(e) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(f) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    1.02      0.95      0.87 %(f) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 15,007      $ 7,365      $ 5,495  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(g)

    12      12      0 %(e)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS

  55


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Innovative Healthcare ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 24.74      $ 26.03      $ 24.97  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.43        0.37        0.11  

Net realized and unrealized gain (loss)(c)

    5.72        (1.15      1.04  
 

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    6.15        (0.78      1.15  
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.38      (0.36      (0.09

From net realized gain

    (0.48      (0.15       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.86      (0.51      (0.09
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 30.03      $ 24.74      $ 26.03  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    25.31      (3.04 )%       4.62 %(e) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(f) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    1.53      1.45      1.25 %(f) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 21,021      $ 4,949      $ 5,206  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(g)

    24      8      3 %(e)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

56  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Media and Entertainment ETF  
     
Year Ended
07/31/20
 
 
    
Year Ended
07/31/19
 
 
    

Period From
03/21/18

to 07/31/18

 
(a)  

 

Net asset value, beginning of period

  $ 28.22      $ 26.38      $ 25.05  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.20        0.26        0.10  

Net realized and unrealized gain (loss)(c)

    (0.86      1.97        1.29  
 

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    (0.66      2.23        1.39  
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.21      (0.26      (0.06

From net realized gain

    (1.01      (0.13       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (1.22      (0.39      (0.06
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 26.34      $ 28.22      $ 26.38  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    (2.33 )%       8.64      5.54 %(e) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(f) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    0.79      0.99      1.04 %(f) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 9,218      $ 7,056      $ 5,277  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(g)

    16      10      0 %(e)  
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS

  57


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Technology ETF  
     
Year Ended
07/31/20

 
    
Year Ended
07/31/19

 
    

Period From
03/21/18

to 07/31/18


(a)  

 

Net asset value, beginning of period

  $ 29.95      $ 26.33      $ 24.89  
 

 

 

    

 

 

    

 

 

 

Net investment income(b)

    0.24        0.23        0.06  

Net realized and unrealized gain(c)

    10.80        3.73        1.43  
 

 

 

    

 

 

    

 

 

 

Net increase from investment operations

    11.04        3.96        1.49  
 

 

 

    

 

 

    

 

 

 

Distributions(d)

       

From net investment income

    (0.24      (0.27      (0.05

From net realized gain

    (0.05      (0.07       
 

 

 

    

 

 

    

 

 

 

Total distributions

    (0.29      (0.34      (0.05
 

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 40.70      $ 29.95      $ 26.33  
 

 

 

    

 

 

    

 

 

 

Total Return

       

Based on net asset value

    37.15      15.27      6.00 %(e) 
 

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets

       

Total expenses

    0.18      0.18      0.18 %(f) 
 

 

 

    

 

 

    

 

 

 

Net investment income

    0.72      0.85      0.70 %(f) 
 

 

 

    

 

 

    

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 79,355      $ 16,470      $ 5,266  
 

 

 

    

 

 

    

 

 

 

Portfolio turnover rate(g)

    5      7      0 %(e) 
 

 

 

    

 

 

    

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

58  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements

 

1.

ORGANIZATION

iShares U.S. ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust and is authorized to have multiple series or portfolios.

These financial statements relate only to the following funds (each, a “Fund,” and collectively, the “Funds”):

 

iShares ETF   Diversification
Classification
 

Evolved U.S. Consumer Staples

    Non-diversified  

Evolved U.S. Discretionary Spending

    Non-diversified  

Evolved U.S. Financials

    Non-diversified  

Evolved U.S. Healthcare Staples

    Non-diversified  

Evolved U.S. Innovative Healthcare

    Non-diversified  

Evolved U.S. Media and Entertainment

    Non-diversified  

Evolved U.S. Technology

    Non-diversified  

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The following significant accounting policies are consistently followed by each Fund in the preparation of its financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies.

Investment Transactions and Income Recognition: Investment transactions are accounted for on trade date. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recognized on the ex-dividend date, net of any foreign taxes withheld at source. Any taxes withheld that are reclaimable from foreign tax authorities are reflected in tax reclaims receivable. Distributions received by the Funds may include a return of capital that is estimated by management. Such amounts are recorded as a reduction of the cost of investments or reclassified to capital gains. Upon notification from issuers, some of the dividend income received from a real estate investment trust may be re-designated as a return of capital or capital gain. Non-cash dividends, if any, are recognized on the ex-dividend date and recorded as non-cash dividend income at fair value. Interest income is accrued daily.

Foreign Taxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its statement of operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “other foreign taxes”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of July 31, 2020, if any, are disclosed in the statement of assets and liabilities.

In-kind Redemptions: For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the Funds. Because such gains or losses are not taxable to the Funds and are not distributed to existing Fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the Funds’ tax year. These reclassifications have no effect on net assets or net asset value (“NAV”) per share.

Distributions: Dividends and distributions paid by each Fund are recorded on the ex-dividend dates. Distributions are determined on a tax basis and may differ from net investment income and net realized capital gains for financial reporting purposes. Dividends and distributions are paid in U.S. dollars and cannot be automatically reinvested in additional shares of the Funds.

Indemnifications: In the normal course of business, each Fund enters into contracts that contain a variety of representations that provide general indemnification. The Funds’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Funds, which cannot be predicted with any certainty.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund’s listing exchange is open and, for financial reporting purposes, as of the report date should the reporting period end on a day that the Fund’s listing exchange is not open. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. A fund determines the fair value of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with a policy approved by the Board as reflecting fair value. The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.

 

 

NOTES TO FINANCIAL STATEMENTS

  59


Notes to Financial Statements  (continued)

 

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s last traded price or official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day are valued at the last traded price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published NAV.

If events (e.g., a company announcement, market volatility or a natural disaster) occur that are expected to materially affect the value of an investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, in accordance with policies approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Global Valuation Committee include market approach, income approach and the cost approach. Valuation techniques used under these approaches take into consideration inputs that include but are not limited to (i) attributes specific to the investment; (ii) the principal market for the investment; (iii) the customary participants in the principal market for the investment; (iv) data assumptions by market participants for the investment, if reasonably available; (v) quoted prices for similar investments in active markets; and (vi) other inputs, such as future cash flows, interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and/or default rates.

When determining the price for Fair Valued Investments, the Global Valuation Committee, or its delegate, seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Global Valuation Committee, or its delegate, deems relevant and consistent with the principles of fair value measurement.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 — Unadjusted price quotations in active markets for identical assets or liabilities;

 

   

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs; and

 

   

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, (including the Global Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgement exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The fair value hierarchy for each Fund’s investments is included in its schedule of investments. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

 

4.

SECURITIES AND OTHER INVESTMENTS

Securities Lending: Each Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by an approved bank, or securities issued or guaranteed by the U.S. government. The initial collateral received by each Fund is required to have a value of at least 102% of the current market value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund or excess collateral is returned by the Fund, on the next business day. During the term of the loan, each Fund is entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of July 31, 2020, any securities on loan were collateralized by cash and/or U.S. government obligations. Cash collateral received was invested in money market funds managed by BlackRock Fund Advisors (“BFA”), the Funds’ investment adviser, or its affiliates and is disclosed in the schedules of investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan for each Fund, if any, are also disclosed in its schedule of investments. The market value of any securities on loan as of July 31, 2020 and the value of the related cash collateral are disclosed in the statements of assets and liabilities.

Securities lending transactions are entered into by a fund under Master Securities Lending Agreements (each, an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. The value of the collateral is typically greater than the market value of the securities loaned, leaving the lender with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the fund can reinvest cash collateral received in connection with loaned securities.

The following table is a summary of the securities lending agreements by counterparty which are subject to offset under an MSLA as of July 31, 2020:

 

 

60  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

iShares ETF and Counterparty   Market Value of
Securities on Loan
     Cash Collateral
Received(a)
     Non-Cash Collateral
Received
     Net Amount  

Evolved U.S. Consumer Staples

          

Citigroup Global Markets Inc.

  $ 23,988      $ 23,988      $      $  

UBS AG

    135,845        135,845                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 159,833      $ 159,833      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Discretionary Spending

          

Citigroup Global Markets Inc.

  $ 1,392      $ 1,392      $      $  

Morgan Stanley & Co. LLC

    2,990        2,990                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 4,382      $ 4,382      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Financials

          

Citigroup Global Markets Inc.

  $ 5,309      $ 5,287      $      $ (22 )(b)  

Morgan Stanley & Co. LLC

    1,376        1,376                

UBS AG

    1,731        1,731                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 8,416      $ 8,394      $      $ (22
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Healthcare Staples

          

Barclays Capital Inc.

  $ 23,474      $ 23,474      $      $  

Credit Suisse Securities (USA) LLC

    191,080        191,080                

Nomura Securities International Inc.

    1,827        1,827                

RBC Capital Markets LLC

    1,133        1,133                

SG Americas Securities LLC

    2,252        2,252                

UBS AG

    2,581        2,581                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 222,347      $ 222,347      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Innovative Healthcare

          

Barclays Capital Inc.

  $ 21,826      $ 21,826      $      $  

Citadel Clearing LLC

    2,243        2,243                

Citigroup Global Markets Inc.

    26,245        26,245                

Credit Suisse Securities (USA) LLC

    276        276                

HSBC Bank PLC

    582        582                

Morgan Stanley & Co. LLC

    164,094        164,094                

RBC Capital Markets LLC

    51,850        51,850                

SG Americas Securities LLC

    8,471        8,471                

UBS AG

    127,260        127,260                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 402,847      $ 402,847      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Media and Entertainment

          

Citigroup Global Markets Inc.

  $ 292,744      $ 291,298      $      $ (1,446 )(b) 

Credit Suisse Securities (USA) LLC

    632        632                

Morgan Stanley & Co. LLC

    3,111        3,111                

RBC Capital Markets LLC

    143,780        143,780                

SG Americas Securities LLC

    66,120        65,533               (587 )(b)  
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 506,387      $ 504,354      $      $ (2,033
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Technology

          

Morgan Stanley & Co. LLC

  $ 67,805      $ 67,805      $      $  

UBS AG

    9,605        9,140               (465 )(b)  
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 77,410      $ 76,945      $      $ (465
 

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Fund’s statement of assets and liabilities.

 
  (b) 

Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by a counterparty.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BlackRock, Inc. (“BlackRock”). BlackRock’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value of the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by each Fund.

 

 

NOTES TO FINANCIAL STATEMENTS

  61


Notes to Financial Statements  (continued)

 

5.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory Fees: Pursuant to an Investment Advisory Agreement with the Trust, BFA manages the investment of each Fund’s assets. BFA is a California corporation indirectly owned by BlackRock. Under the Investment Advisory Agreement, BFA is responsible for substantially all expenses of the Funds, except (i) interest and taxes; (ii) brokerage commissions and other expenses connected with the execution of portfolio transactions; (iii) distribution fees; (iv) the advisory fee payable to BFA; and (v) litigation expenses and any extraordinary expenses (in each case as determined by a majority of the independent trustees).

For its investment advisory services to each Fund, BFA is entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on the average daily net assets of each Fund as follows:

 

iShares ETF   Investment Advisory Fee  

Evolved U.S. Consumer Staples

    0.18

Evolved U.S. Discretionary Spending

    0.18  

Evolved U.S. Financials

    0.18  

Evolved U.S. Healthcare Staples

    0.18  

Evolved U.S. Innovative Healthcare

    0.18  

Evolved U.S. Media and Entertainment

    0.18  

Evolved U.S. Technology

    0.18  

Distributor: BlackRock Investments, LLC, an affiliate of BFA, is the distributor for each Fund. Pursuant to the distribution agreement, BFA is responsible for any fees or expenses for distribution services provided to the Funds.

Securities Lending: The U.S. Securities and Exchange Commission (the “SEC”) has issued an exemptive order which permits BlackRock Institutional Trust Company, N.A. (“BTC”), an affiliate of BFA, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending. Each Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan in a money market fund managed by BFA, or its affiliates, however, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees each Fund bears to an annual rate of 0.04% (the “collateral investment fees”). Securities lending income is equal to the total of income earned from the reinvestment of cash collateral (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities. Each Fund retains a portion of securities lending income and remits the remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, each Fund retains 75% of securities lending income (which excludes collateral investment fees) and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all 1940 Act iShares exchange-traded funds (the “iShares ETF Complex”) in that calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year 80% of securities lending income (which excludes collateral investment fees), and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

Prior to January 1, 2020, each Fund retained 73.5% of securities lending income (which excludes collateral investment fees) and the amount retained was not less than 70% of the total of securities lending income plus the collateral investment fees. In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across the iShares ETF Complex in a calendar year exceeded a specified threshold, each Fund, pursuant to the securities lending agreement, retained for the remainder of that calendar year 80% of securities lending income (which excludes collateral investment fees), and the amount retained could never be less than 70% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in its statement of operations. For the year ended July 31, 2020, the Funds paid BTC the following amounts for securities lending agent services:

 

iShares ETF   Fees Paid
to BTC
 

Evolved U.S. Consumer Staples

  $ 500  

Evolved U.S. Discretionary Spending

    385  

Evolved U.S. Financials

    36  

Evolved U.S. Healthcare Staples

    430  

Evolved U.S. Innovative Healthcare

    1,333  

Evolved U.S. Media and Entertainment

    876  

Evolved U.S. Technology

    1,025  

Officers and Trustees: Certain officers and/or trustees of the Trust are officers and/or trustees of BlackRock or its affiliates.

Each Fund may invest its positive cash balances in certain money market funds managed by BFA or an affiliate. The income earned on these temporary cash investments is shown as dividends — affiliated in the statement of operations.

 

 

62  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

 

6.

PURCHASES AND SALES

For the year ended July 31, 2020, purchases and sales of investments, excluding in-kind transactions and short-term investments, were as follows:

 

iShares ETF   Purchases      Sales  

Evolved U.S. Consumer Staples

  $ 1,060,092      $ 1,045,583  

Evolved U.S. Discretionary Spending

    998,780        986,101  

Evolved U.S. Financials

    370,545        375,619  

Evolved U.S. Healthcare Staples

    1,282,746        1,305,420  

Evolved U.S. Innovative Healthcare

    2,490,973        2,183,485  

Evolved U.S. Media and Entertainment

    1,042,916        1,255,018  

Evolved U.S. Technology

    1,676,865        1,615,546  

For the year ended July 31, 2020, in-kind transactions were as follows:

 

iShares ETF   In-kind
Purchases
     In-kind
Sales
 

Evolved U.S. Consumer Staples

  $ 5,314,611      $  

Evolved U.S. Discretionary Spending

    8,658,761        4,266,377  

Evolved U.S. Healthcare Staples

    7,260,926        1,282,244  

Evolved U.S. Innovative Healthcare

    13,965,286         

Evolved U.S. Media and Entertainment

    3,518,079        1,350,786  

Evolved U.S. Technology

    49,424,512         

 

7.

INCOME TAX INFORMATION

Each Fund is treated as an entity separate from the Trust’s other funds for federal income tax purposes. It is the policy of each Fund to qualify as a regulated investment company by complying with the provisions applicable to regulated investment companies, as defined under Subchapter M of the Internal Revenue Code of 1986, as amended, and to annually distribute substantially all of its ordinary income and any net capital gains (taking into account any capital loss carryforwards) sufficient to relieve it from all, or substantially all, federal income and excise taxes. Accordingly, no provision for federal income taxes is required.

Management has analyzed tax laws and regulations and their application to the Funds as of July 31, 2020, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAV per share. As of July 31, 2020, the following permanent differences attributable to realized gains (losses) from in-kind redemptions, were reclassified to the following accounts:

 

iShares ETF   Paid-in Capital      Accumulated
Earnings (Loss)
 

Evolved U.S. Consumer Staples

  $ 4,246      $ (4,246

Evolved U.S. Discretionary Spending

    1,012,528        (1,012,528

Evolved U.S. Healthcare Staples

    205,117        (205,117

Evolved U.S. Media and Entertainment

    210,589        (210,589

The tax character of distributions paid was as follows:

 

iShares ETF   Year Ended
07/31/20
     Year Ended
07/31/19
 

Evolved U.S. Consumer Staples

    

Ordinary income

  $ 191,747      $ 135,321  
 

 

 

    

 

 

 

Evolved U.S. Discretionary Spending

    

Ordinary income

  $ 128,050      $ 92,875  

Long-term capital gains

    40,904         
 

 

 

    

 

 

 
  $ 168,954      $ 92,875  
 

 

 

    

 

 

 

Evolved U.S. Financials

    

Ordinary income

  $ 112,279      $ 100,143  
 

 

 

    

 

 

 

Evolved U.S. Healthcare Staples

    

Ordinary income

  $ 157,162      $ 80,138  

Long-term capital gains

    1,480         
 

 

 

    

 

 

 
  $ 158,642      $ 80,138  
 

 

 

    

 

 

 

 

 

NOTES TO FINANCIAL STATEMENTS

  63


Notes to Financial Statements  (continued)

 

iShares ETF   Year Ended
07/31/20
    

Year Ended

07/31/19

 

Evolved U.S. Innovative Healthcare

    

Ordinary income

  $ 132,150      $ 100,052  

Long-term capital gains

    68,177         
 

 

 

    

 

 

 
  $ 200,327      $ 100,052  
 

 

 

    

 

 

 

Evolved U.S. Media and Entertainment

    

Ordinary income

  $ 235,056      $ 81,138  

Long-term capital gains

    16,940         
 

 

 

    

 

 

 
  $ 251,996      $ 81,138  
 

 

 

    

 

 

 

Evolved U.S. Technology

    

Ordinary income

  $ 207,812      $ 74,296  

Long-term capital gains

    12,785         
 

 

 

    

 

 

 
  $ 220,597      $ 74,296  
 

 

 

    

 

 

 

As of July 31, 2020, the tax components of accumulated net earnings (losses) were as follows:

 

iShares ETF    
Undistributed
Ordinary Income
 
 
   
Undistributed
Long-Term Capital Gains
 
 
   

Non-expiring
Capital Loss
Carryforwards
 
 
(a) 
   
Net Unrealized
Gains (Losses)
 
(b) 
   
Qualified
Late-Year Losses
 
 
    Total  

Evolved U.S. Consumer Staples

  $ 37,003     $     $ (58,398   $ 816,453     $     $ 795,058  

Evolved U.S. Discretionary Spending

    3,814                   1,587,923       (58,764     1,532,973  

Evolved U.S. Financials

    11,503             (25,476     (809,290           (823,263

Evolved U.S. Healthcare Staples

    23,521             (20,446     2,245,637             2,248,712  

Evolved U.S. Innovative Healthcare

    62,321       108,453             1,533,195             1,703,969  

Evolved U.S. Media and Entertainment

    11,173                   481,650             492,823  

Evolved U.S. Technology

    20,496             (32,554     14,534,694             14,522,636  

 

  (a) 

Amounts available to offset future realized capital gains.

 
  (b) 

The difference between book-basis and tax-basis unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales and the characterization of corporate actions.

 

For the year ended July 31, 2020, the iShares Evolved U.S. Financials ETF utilized $18,865 of its capital loss carryforwards.

As of July 31, 2020, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

iShares ETF   Tax Cost      Gross Unrealized
Appreciation
     Gross Unrealized
Depreciation
    Net Unrealized
Appreciation
(Depreciation)
 

Evolved U.S. Consumer Staples

  $ 9,195,355      $ 1,121,163      $ (304,710   $ 816,453  

Evolved U.S. Discretionary Spending

    10,386,952        2,506,114        (918,191     1,587,923  

Evolved U.S. Financials

    4,925,773        311,315        (1,120,605     (809,290

Evolved U.S. Healthcare Staples

    12,971,264        2,437,132        (191,495     2,245,637  

Evolved U.S. Innovative Healthcare

    19,884,119        2,196,145        (662,950     1,533,195  

Evolved U.S. Media and Entertainment

    9,236,123        1,307,589        (825,939     481,650  

Evolved U.S. Technology

    64,897,436        15,068,749        (534,055     14,534,694  

 

8.

PRINCIPAL RISKS

In the normal course of business, each Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including, among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate or price fluctuations. Each Fund’s prospectus provides details of the risks to which the Fund is subject.

Market Risk: Market risk arises mainly from uncertainty about future values of financial instruments influenced by price, currency and interest rate movements. It represents the potential loss a fund may suffer through holding market positions in the face of market movements. A fund is exposed to market risk by its investment in equity, fixed income and/or financial derivative instruments or by its investment in underlying funds. The fair value of securities held by a fund may decline due to general market conditions, economic trends or events that are not specifically related to the issuers of the securities including local, regional or global political, social or economic instability or to factors that affect a particular industry or group of industries. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public

 

 

64  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

health issues, recessions, or other events could have a significant impact on the Funds and their investments. The extent of a fund’s exposure to market risk is the market value of the investments held as shown in the fund’s schedule of investments.

An outbreak of respiratory disease caused by a novel coronavirus has developed into a global pandemic and has resulted in closing borders, quarantines, disruptions to supply chains and customer activity, as well as general concern and uncertainty. The impact of this pandemic, and other global health crises that may arise in the future, could affect the economies of many nations, individual companies and the market in general in ways that cannot necessarily be foreseen at the present time. This pandemic may result in substantial market volatility and may adversely impact the prices and liquidity of a fund’s investments. The duration of this pandemic and its effects cannot be determined with certainty.

Credit Risk: Credit risk is the risk that an issuer or guarantor of debt instruments or the counterparty to a financial transaction, including derivatives contracts, repurchase agreements or loans of portfolio securities, is unable or unwilling to make timely interest and/or principal payments or to otherwise honor its obligations. BFA and its affiliates manage counterparty credit risk by entering into transactions only with counterparties that they believe have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose a fund to issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of a fund’s exposure to credit and counterparty risks with respect to those financial assets is approximated by their value recorded in its statement of assets and liabilities.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its schedule of investments.

When a fund concentrates its investments in securities within a single or limited number of market sectors, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the fund and could affect the income from, or the value or liquidity of, the fund’s portfolio.

LIBOR Transition Risk: The United Kingdom’s Financial Conduct Authority announced a phase out of the London Interbank Offered Rate (“LIBOR”) by the end of 2021, and it is expected that LIBOR will cease to be published after that time. The Funds may be exposed to financial instruments tied to LIBOR to determine payment obligations, financing terms, hedging strategies or investment value. The transition process away from LIBOR might lead to increased volatility and illiquidity in markets for, and reduce the effectiveness of new hedges placed against, instruments whose terms currently include LIBOR. The ultimate effect of the LIBOR transition process on the Funds is uncertain.

 

9.

CAPITAL SHARE TRANSACTIONS

Capital shares are issued and redeemed by each Fund only in aggregations of a specified number of shares or multiples thereof (“Creation Units”) at NAV. Except when aggregated in Creation Units, shares of each Fund are not redeemable.

Transactions in capital shares were as follows:

 

     Year Ended
07/31/20
    Year Ended
07/31/19
 
iShares ETF   Shares     Amount     Shares     Amount  

Evolved U.S. Consumer Staples

       

Shares sold

    200,000     $ 5,356,261           $  
 

 

 

   

 

 

   

 

 

   

 

 

 

Evolved U.S. Discretionary Spending

       

Shares sold

    300,000     $ 8,824,906           $  

Shares redeemed

    (150,000     (4,347,317            
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase

    150,000     $ 4,477,589           $  
 

 

 

   

 

 

   

 

 

   

 

 

 

Evolved U.S. Healthcare Staples

       

Shares sold

    250,000     $ 7,330,427       100,000     $ 2,773,961  

Shares redeemed

    (50,000     (1,298,075     (50,000     (1,338,232
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase

    200,000     $ 6,032,352       50,000     $ 1,435,729  
 

 

 

   

 

 

   

 

 

   

 

 

 

Evolved U.S. Innovative Healthcare

       

Shares sold

    500,000     $ 14,398,781           $  
 

 

 

   

 

 

   

 

 

   

 

 

 

Evolved U.S. Media and Entertainment

       

Shares sold

    150,000     $ 3,548,987       50,000     $ 1,347,171  

Shares redeemed

    (50,000     (1,361,022            
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase

    100,000     $ 2,187,965       50,000     $ 1,347,171  
 

 

 

   

 

 

   

 

 

   

 

 

 

Evolved U.S. Technology

       

Shares sold

    1,400,000     $ 49,763,348       350,000     $ 10,161,391  
 

 

 

   

 

 

   

 

 

   

 

 

 

The consideration for the purchase of Creation Units of a fund in the Trust generally consists of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Certain funds in the Trust may be offered in Creation Units solely or partially for cash in U.S. dollars. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to State Street Bank and Trust Company, the Trust’s administrator, to offset transfer and other

 

 

NOTES TO FINANCIAL STATEMENTS

  65


Notes to Financial Statements  (continued)

 

transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. Investors transacting in Creation Units for cash may also pay an additional variable charge to compensate the relevant fund for certain transaction costs (i.e., stamp taxes, taxes on currency or other financial transactions, and brokerage costs) and market impact expenses relating to investing in portfolio securities. Such variable charges, if any, are included in shares sold in the table above.

From time to time, settlement of securities related to in-kind contributions or in-kind redemptions may be delayed. In such cases, securities related to in-kind transactions are reflected as a receivable or a payable in the statement of assets and liabilities.

 

10.

LEGAL PROCEEDINGS

On June 16, 2016, investors in certain iShares funds (iShares Core S&P Small-Cap ETF, iShares Russell 1000 Growth ETF, iShares Core S&P 500 ETF, iShares Russell Mid-Cap Growth ETF, iShares Russell Mid-Cap ETF, iShares Russell Mid-Cap Value ETF, iShares Select Dividend ETF, iShares Morningstar Mid-Cap ETF, iShares Morningstar Large-Cap ETF, iShares U.S. Aerospace & Defense ETF and iShares Preferred and Income Securities ETF) filed a class action lawsuit against iShares Trust, BlackRock, Inc. and certain of its advisory affiliates, and certain directors/trustees and officers of the Funds (collectively, “Defendants”) in California State Court. The lawsuit alleges the Defendants violated federal securities laws by failing to adequately disclose in the prospectuses issued by the funds noted above the risks of using stop-loss orders in the event of a ‘flash crash’, such as the one that occurred on May 6, 2010. On September 18, 2017, the court issued a Statement of Decision holding that the Plaintiffs lack standing to assert their claims. On October 11, 2017, the court entered final judgment dismissing all of the Plaintiffs’ claims with prejudice. In an opinion dated January 23, 2020, the California Court of Appeal affirmed the dismissal of Plaintiffs’ claims. On March 3, 2020, plaintiffs filed a petition for review by the California Supreme Court. On May 27, 2020, the California Supreme Court denied Plaintiff’s petition for review. The case is now closed.

 

11.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were available to be issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

66  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees of iShares U.S. ETF Trust and

Shareholders of iShares Evolved U.S. Consumer Staples ETF,

iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF,

iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF,

iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF (seven of the funds constituting iShares U.S. ETF Trust, hereafter collectively referred to as the “Funds”) as of July 31, 2020, the related statements of operations for the year ended July 31, 2020, the statements of changes in net assets for each of the two years in the period ended July 31, 2020, including the related notes, and the financial highlights for each of the periods indicated therein (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of July 31, 2020, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended July 31, 2020 and each of the financial highlights for each of the periods indicated therein in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of July 31, 2020 by correspondence with the custodian, transfer agent and brokers. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

September 21, 2020

We have served as the auditor of one or more BlackRock investment companies since 2000.

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

  67


Important Tax Information  (unaudited)   

 

For corporate shareholders, the percentage of ordinary income distributions paid during the fiscal year ended July 31, 2020 that qualified for the dividends-received deduction were as follows:

 

iShares ETF   Dividends-Received
Deduction
 

Evolved U.S. Consumer Staples

    100.00

Evolved U.S. Discretionary Spending

    100.00

Evolved U.S. Financials

    100.00

Evolved U.S. Healthcare Staples

    91.69

Evolved U.S. Innovative Healthcare

    88.98

Evolved U.S. Media and Entertainment

    95.47

Evolved U.S. Technology

    100.00

The following maximum amounts are hereby designated as qualified dividend income for individuals for the fiscal year ended July 31, 2020:

 

iShares ETF   Qualified Dividend
Income
 

Evolved U.S. Consumer Staples

  $ 227,394  

Evolved U.S. Discretionary Spending

    132,922  

Evolved U.S. Financials

    121,879  

Evolved U.S. Healthcare Staples

    117,877  

Evolved U.S. Innovative Healthcare

    144,460  

Evolved U.S. Media and Entertainment

    59,140  

Evolved U.S. Technology

    258,484  

The following maximum amounts are hereby designated as qualified business income for individuals for the fiscal year ended July 31, 2020:

 

iShares ETF   Qualified Business
Income
 

Evolved U.S. Consumer Staples

  $ 212  

Evolved U.S. Financials

    546  

Evolved U.S. Healthcare Staples

    1,995  

Evolved U.S. Media and Entertainment

    683  

Evolved U.S. Technology

    625  

The following distribution amounts are hereby designated for the fiscal year ended July 31, 2020:

 

iShares ETF   Short-Term
Capital Gain
Dividends
     20% Rate
Long-Term
Capital Gain
Dividends
 

Evolved U.S. Discretionary Spending

  $ 13,440      $ 40,904  

Evolved U.S. Healthcare Staples

    71,622        1,480  

Evolved U.S. Innovative Healthcare

    28,381        68,177  

Evolved U.S. Media and Entertainment

    184,756        16,940  

Evolved U.S. Technology

    15,719        12,785  

 

 

68  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Board Review and Approval of Investment Advisory Contract

 

iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media And Entertainment ETF, iShares Evolved U.S. Technology ETF (each the “Fund”)

Under Section 15(c) of the Investment Company Act of 1940 (the “1940 Act”), the Trust’s Board of Trustees (the “Board”), including a majority of Board Members who are not “interested persons” of the Trust (as that term is defined in the 1940Act) (the “Independent Board Members), is required annually to consider and approve the Investment Advisory Contract between the Trust and BFA (the “Advisory Contract”) whereby the Board and its committees (composed solely of Independent Board Members) assess BlackRock’s services to the Fund, including investment management; fund accounting; administrative and shareholder services; oversight of the Fund’s service providers; risk management and oversight; legal and compliance services; and ability to meet applicable legal and regulatory requirements. The Independent Board Members requested, and BFA provided, such information as the Independent Board Members, with advice from independent counsel, deemed reasonably necessary to evaluate the Advisory Contract. At meetings on April 17, 2020 and May 19, 2020, a committee composed of all of the Independent Board Members (the “15(c) Committee”), with independent counsel, met with management and reviewed and discussed information provided in response to initial requests of the 15(c) Committee and/or its independent counsel, and requested certain additional information, which management agreed to provide. At a meeting held on June 8-10, 2020, the Board, including the Independent Board Members, reviewed the additional information provided by management in response to these requests.

After extensive discussions and deliberations, the Board, including all of the Independent Board Members, approved the continuance of the Advisory Contract for the Fund, based on a review of qualitative and quantitative information provided by BFA and their cumulative experience as Board Members. The Board noted its satisfaction with the extent and quality of information provided and its frequent interactions with management, as well as the detailed responses and other information provided by BFA. The Independent Board Members were advised by their independent counsel throughout the process, including about the legal standards applicable to their review. In approving the continuance of the Advisory Contract for the Fund, the Board, including the Independent Board Members, considered various factors, including: (i) the expenses and performance of the Fund; (ii) the nature, extent and quality of the services provided by BFA; (iii) the costs of services provided to the Fund and profits realized by BFA and its affiliates; (iv) potential economies of scale and the sharing of related benefits; (v) the fees and services provided for other comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, none of which was controlling, and conclusions that formed the basis for the Board, including the Independent Board Members, to approve the continuance of the Advisory Contract are discussed below.

Expenses and Performance of the Fund: The Board reviewed statistical information prepared by Broadridge Financial Solutions Inc. (“Broadridge”), an independent provider of investment company data, regarding the expense ratio components, including gross and net total expenses, fees and expenses of another fund in which the Fund invests (if applicable), and waivers/reimbursements (if applicable) of the Fund in comparison with the same information for other ETFs (including, where applicable, funds sponsored by an “at cost” service provider), objectively selected by Broadridge as comprising the Fund’s applicable peer group pursuant to Broadridge’s proprietary ETF methodology (the “Peer Group”). The Board was provided with a detailed description of the proprietary ETF methodology used by Broadridge to determine the Fund’s Peer Group. The Board noted that, due to the limitations in providing comparable funds in the Peer Group, the statistical information provided in Broadridge’s report may or may not provide meaningful direct comparisons to the Fund in all instances. The Board also noted that overall fund expenses (net of waivers and reimbursements) for the Fund were lower than the median of the overall fund expenses (net of waivers and reimbursements ) of the funds in its Peer Group, excluding iShares funds.

The Board noted that the Fund is an actively managed ETF that does not seek to track the performance of a specified index and that the management team for the Fund manages the Fund’s portfolio in accordance with its investment objective. The Board further noted that, during the year, the Board received periodic reports on the Fund’s short- and longer-term performance in comparison with its reference benchmark. Such periodic comparative performance information, including additional detailed information as requested by the Board, was also considered. The Board noted that the Fund generally performed in line with expectations relative to the Fund’s peer group (where applicable) and reference benchmark.

Based on this review, the other factors considered at the meeting, and their general knowledge of ETF pricing, the Board concluded that the investment advisory fee rate and expense level and the historical performance of the Fund supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Nature, Extent and Quality of Services Provided: Based on management’s representations, including information about recent and proposed enhancements to the iShares business, including with respect to capital markets support and analysis, technology, portfolio management, product design and quality, compliance and risk management, global public policy and other services, the Board expected that there would be no diminution in the scope of services required of or provided by BFA under the Advisory Contract for the coming year as compared with the scope of services provided by BFA during prior years. In reviewing the scope of these services, the Board considered BFA’s investment philosophy and experience, noting that BFA and its affiliates have committed significant resources over time, including during the past year, to support the iShares funds and their shareholders and have made significant investments into the iShares business. The Board also considered BFA’s compliance program and its compliance record with respect to the Fund. In that regard, the Board noted that BFA reports to the Board about portfolio management and compliance matters on a periodic basis in connection with regularly scheduled meetings of the Board, and on other occasions as necessary and appropriate, and has provided information and made relevant officers and other employees of BFA (and its affiliates) available as needed to provide further assistance with these matters. The Board also reviewed the background and experience of the persons responsible for the day-to-day management of the Fund, as well as the resources available to them in managing the Fund. In addition to the above considerations, the Board reviewed and considered detailed presentations regarding BFA’s investment performance, investment and risk management processes and strategies, which were provided at the June 8-10, 2020 meeting and throughout the year.

Based on review of this information, and the performance information discussed above, the Board concluded that the nature, extent and quality of services provided to the Fund under the Advisory Contract supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Costs of Services Provided to the Fund and Profits Realized by BFA and its Affiliates: The Board reviewed information about the estimated profitability to BlackRock in managing the Fund, based on the fees payable to BFA and its affiliates (including fees under the Advisory Contract), and other sources of revenue and expense to BFA and its affiliates from the Fund’s operations for the last calendar year. The Board reviewed BlackRock’s methodology for calculating estimated profitability of the iShares

 

 

BOARD REVIEW AND APPROVAL OF INVESTMENT ADVISORY CONTRACT

  69


Board Review and Approval of Investment Advisory Contract  (continued)

 

funds, noting that the 15(c) Committee and the Board had focused on the methodology and profitability presentation. The Board recognized that profitability may be affected by numerous factors including, among other things, fee waivers by BFA, the types of funds managed, expense allocations and business mix. The Board thus recognized that calculating and comparing profitability at individual fund levels is challenging. The Board discussed with management the sources of direct and ancillary revenue, including the revenues to BTC, a BlackRock affiliate, from securities lending by the Fund. The Board also discussed BFA’s estimated profit margin as reflected in the Fund’s profitability analysis and reviewed information regarding potential economies of scale (as discussed below).

Based on this review, the Board concluded that the profits realized by BFA and its affiliates under the Advisory Contract and from other relationships between the Fund and BFA and/or its affiliates, if any, were within a reasonable range in light of the factors and other information considered.

Economies of Scale: The Board reviewed information and considered the extent to which economies of scale might be realized as the assets of the Fund increase, noting that the issue of potential economies of scale had been focused on by the 15(c) Committee and the Board during their meetings and addressed by management. The 15(c) Committee and the Board received information regarding BlackRock’s historical estimated profitability, including BFA’s and its affiliates’ estimated costs in providing services. The estimated cost information distinguished, among other things, between fixed and variable costs, and showed how the level and nature of fixed and variable costs may impact the existence or size of scale benefits, with the Board recognizing that potential economies of scale are difficult to measure. The 15(c) Committee and the Board reviewed information provided by BFA regarding the sharing of scale benefits with the iShares funds through various means, including, as applicable, through relatively low fee rates established at inception, breakpoints, waivers, or other fee reductions, as well as through additional investment in the iShares business and the provision of improved or additional infrastructure and services to the iShares funds and their shareholders. The Board noted that the Advisory Contract for the Fund did not provide for breakpoints in the Fund’s investment advisory fee rate as the assets of the Fund increase. However, the Board would continue to assess the appropriateness of adding breakpoints in the future.

The Board concluded that this review of potential economies of scale and the sharing of related benefits, as well as the other factors considered at the meeting, supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Fees and Services Provided for Other Comparable Funds/Accounts Managed by BFA and its Affiliates: The Board considered information regarding the investment advisory/management fee rates for other funds/accounts in the U.S. for which BFA (or its affiliates) provides investment advisory/management services, including open-end funds registered under the 1940 Act (including sub-advised funds), collective trust funds, and institutional separate accounts (collectively, the “Other Accounts”). The Board acknowledged BFA’s representation that the iShares funds are fundamentally different investment vehicles from the Other Accounts. The Board noted that BFA and its affiliates do not manage Other Accounts with a similar investment strategy or investment mandate as the Fund. The Board further noted that BFA provided the Board with detailed information regarding how the Other Accounts generally differ from the Fund, including in terms of the types of services and generally more extensive services provided to the Fund, as well as other significant differences. In that regard, the Board considered that the pricing of services to institutional clients is typically based on a number of factors beyond the nature and extent of the specific services to be provided and often depends on the overall relationship between the client and its affiliates and the adviser and its affiliates. In addition, the Board considered the relative complexity and inherent risks and challenges of managing and providing other services to the Fund, as a publicly traded investment vehicle, as compared to the Other Accounts, particularly those that are institutional clients, in light of differing regulatory requirements and client-imposed mandates. The Board also acknowledged management’s assertion that, for certain iShares funds, and for client segmentation purposes, BlackRock has launched an iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate. The Board also considered the “all-inclusive” nature of the Fund’s advisory fee structure, and the Fund’s expenses borne by BFA under this arrangement. The Board noted that the investment advisory fee rate under the Advisory Contract for the Fund was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Other Benefits to BFA and/or its Affiliates: The Board reviewed other benefits or ancillary revenue received by BFA and/or its affiliates in connection with the services provided to the Fund by BFA, both direct and indirect, such as payment of revenue to BTC, the Fund’s securities lending agent, for loaning portfolio securities (which was included in the profit margins reviewed by the Board pursuant to BFA’s estimated profitability methodology), payment of advisory fees or other fees to BFA (or its affiliates) in connection with any investments by the Fund in other funds for which BFA (or its affiliates) provides investment advisory services or other services and BlackRock’s profile in the investment community. The Board also noted the revenue received by BFA and/or its affiliates pursuant to an agreement that permits a service provider to use certain portions of BlackRock’s technology platform to service accounts managed by BFA and/or its affiliates, including the iShares funds. The Board noted that BFA generally does not use soft dollars or consider the value of research or other services that may be provided to BFA (including its affiliates) in selecting brokers for portfolio transactions for the Fund. The Board further noted that any portfolio transactions on behalf of the Fund placed through a BFA affiliate or purchased from an underwriting syndicate in which a BFA affiliate participates (including associated commissions) are reported to the Board pursuant to Rule 17e-1 or Rule 10f-3, as applicable, under the 1940 Act. The Board concluded that any such ancillary benefits would not be disadvantageous to the Fund and thus would not alter the Board’s conclusion with respect to the appropriateness of approving the continuance of the Advisory Contract for the coming year.

Conclusion: Based on a review of the factors described above, as well as such other factors as deemed appropriate by the Board, the Board, including all of the Independent Board Members, determined that the Fund’s investment advisory fee rate under the Advisory Contract does not constitute a fee that is so disproportionately large as to bear no reasonable relationship to the services rendered and that could not have been the product of arm’s-length bargaining, and concluded to approve the continuance of the Advisory Contract for the coming year.

 

 

70  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Supplemental Information  (unaudited)

 

Section 19(a) Notices

The amounts and sources of distributions reported are estimates and are being provided pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each fund’s investment experience during the year and may be subject to changes based on tax regulations. Shareholders will receive a Form 1099-DIV each calendar year that will inform them how to report these distributions for federal income tax purposes.

 

     Total Cumulative Distributions
for the Fiscal Year
    % Breakdown of the Total Cumulative
Distributions for the Fiscal Year
 
iShares ETF   Net
Investment
Income
    Net Realized
Capital Gains
    Return of
Capital
    Total Per
Share
    Net
Investment
Income
    Net Realized
Capital Gains
    Return of
Capital
    Total Per
Share
 

Evolved U.S. Consumer Staples(a)

  $ 0.617865     $     $ 0.002296     $ 0.620161       100         0 %(b)      100

Evolved U.S. Discretionary Spending(a)

    0.334038       0.155269       0.000181       0.489488       68       32       0 (b)      100  

Evolved U.S. Financials(a)

    0.560778             0.000619       0.561397       100             0 (b)      100  

Evolved U.S. Healthcare Staples(a)

    0.243532       0.243674       0.000430       0.487636       50       50       0 (b)      100  

Evolved U.S. Innovative Healthcare

    0.376877       0.482790             0.859667       44       56             100  

Evolved U.S. Media and Entertainment(a)

    0.214483       1.005765       0.000460       1.220708       18       82       0 (b)      100  

Evolved U.S. Technology(a)

    0.234635       0.051826       0.000026       0.286487       82       18       0 (b)      100  

 

  (a) 

The Fund estimates that it has distributed more than its net investment income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in the Fund is returned to the shareholder. A return of capital does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. When distributions exceed total return performance, the difference will incrementally reduce the Fund’s net asset value per share.

 
  (b) 

Rounds to less than 1%.

 

Premium/Discount Information

The Premium/Discount Information section is intended to present information about the differences between the daily market price on secondary markets for shares of a fund and that fund’s NAV. NAV is the price at which a fund issues and redeems shares. It is calculated in accordance with the standard formula for valuing mutual fund shares. The “Market Price” of a fund generally is determined using the midpoint between the highest bid and the lowest ask on the primary securities exchange on which shares of such fund are listed for trading, as of the time that the fund’s NAV is calculated. A fund’s Market Price may be at, above or below its NAV. The NAV of a fund will fluctuate with changes in the value of its portfolio holdings. The Market Price of a fund will fluctuate in accordance with changes in its NAV, as well as market supply and demand.

Premiums or discounts are the differences (expressed as a percentage) between the NAV and Market Price of a fund on a given day, generally at the time the NAV is calculated. A premium is the amount that a fund is trading above the reported NAV, expressed as a percentage of the NAV. A discount is the amount that a fund is trading below the reported NAV, expressed as a percentage of the NAV.

Premium/discount information for the Funds covering the most recently completed calendar year and the most recently completed calendar quarters since that year (or since the Fund began trading, if shorter) is publicly accessible, free of charge, at iShares.com.

The following information shows the frequency of distributions of premiums and discounts for the Funds for the immediately preceding five calendar years (or from the date a Fund began trading on the secondary market, if less than five years) through the date of the most recent calendar quarter-end. Each line in each table shows the number of trading days in which the Fund traded within the premium/discount range indicated. Premium/discount ranges with no trading days are omitted. The number of trading days in each premium/discount range is also shown as a percentage of the total number of trading days in the period covered by each table. All data presented here represents past performance, which cannot be used to predict future results.

iShares Evolved U.S. Consumer Staples ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 1.0% and Less than 1.5%

    1        0.17

Greater than 0.0% and Less than 0.5%

    436        76.23  

At NAV

    37        6.47  

Less than 0.0% and Greater than –0.5%

    98        17.13  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

 

 

SUPPLEMENTAL INFORMATION

  71


Supplemental Information  (unaudited) (continued)

 

iShares Evolved U.S. Discretionary Spending ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.5% and Less than 1.0%

    1        0.17

Greater than 0.0% and Less than 0.5%

    319        55.78  

At NAV

    31        5.42  

Less than 0.0% and Greater than –0.5%

    220        38.46  

Less than –1.0% and Greater than –1.5%

    1        0.17  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Financials ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 2.0% and Less than 2.5%

    1        0.17

Greater than 0.0% and Less than 0.5%

    382        66.79  

At NAV

    52        9.09  

Less than 0.0% and Greater than –0.5%

    137        23.95  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Healthcare Staples ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 2.5% and Less than 3.0%

    1        0.17

Greater than 2.0% and Less than 2.5%

    1        0.17  

Greater than 0.0% and Less than 0.5%

    327        57.18  

At NAV

    41        7.17  

Less than 0.0% and Greater than –0.5%

    202        35.31  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Innovative Healthcare ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.0% and Less than 0.5%

    342        59.79

At NAV

    62        10.84  

Less than 0.0% and Greater than –0.5%

    168        29.37  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Media and Entertainment ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.0% and Less than 0.5%

    316        55.25

At NAV

    61        10.66  

Less than 0.0% and Greater than –0.5%

    195        34.09  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

 

 

72  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Supplemental Information  (unaudited) (continued)

 

iShares Evolved U.S. Technology ETF

Period Covered: March 23, 2018 through June 30, 2020

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 1.0% and Less than 1.5%

    1        0.17

Greater than 0.5% and Less than 1.0%

    1        0.17  

Greater than 0.0% and Less than 0.5%

    485        84.80  

At NAV

    22        3.85  

Less than 0.0% and Greater than –0.5%

    63        11.01  
 

 

 

    

 

 

 
    572        100.00
 

 

 

    

 

 

 

 

 

SUPPLEMENTAL INFORMATION

  73


Trustee and Officer Information

 

The Board of Trustees has responsibility for the overall management and operations of the Funds, including general supervision of the duties performed by BFA and other service providers. Each Trustee serves until he or she resigns, is removed, dies, retires or becomes incapacitated. The President, Chief Compliance Officer, Treasurer and Secretary shall each hold office until their successors are chosen and qualify, and all other officers shall hold office until he or she resigns or is removed. Trustees who are not “interested persons” (as defined in the 1940 Act) of the Trust are referred to as independent trustees (“Independent Trustees”).

The registered investment companies advised by BFA or its affiliates (the “BlackRock-advised Funds”) are organized into one complex of open-end equity, multi-asset, index and money market funds (the “BlackRock Multi-Asset Complex”), one complex of closed-end funds and open-end non-index fixed-income funds (the “BlackRock Fixed-Income Complex”) and one complex of ETFs (“Exchange-Traded Fund Complex”) (each, a “BlackRock Fund Complex”). Each Fund is included in the BlackRock Fund Complex referred to as the Exchange-Traded Fund Complex. Each Trustee also serves as a Director of iShares, Inc. and a Trustee of iShares Trust, and, as a result, oversees all of the funds within the Exchange-Traded Fund Complex, which consists of 374 funds as of July 31, 2020. With the exception of Robert S. Kapito, Salim Ramji and Charles Park, the address of each Trustee and officer is c/o BlackRock, Inc., 400 Howard Street, San Francisco, CA 94105. The address of Mr. Kapito, Mr. Ramji and Mr. Park is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. The Board has designated Cecilia H. Herbert as its Independent Board Chair. Additional information about the Funds’ Trustees and officers may be found in the Funds’ combined Statement of Additional Information, which is available without charge, upon request, by calling toll-free 1-800-iShares (1-800-474-2737).

 

Interested Trustees
       
Name (Age)    Position(s)    Principal Occupation(s)
During the Past 5 Years
   Other Directorships Held by Trustee
Robert S. Kapito(a) (63)    Trustee
(since 2011).
   President, BlackRock, Inc. (since 2006); Vice Chairman of BlackRock, Inc. and Head of BlackRock’s Portfolio Management Group (since its formation in 1998) and BlackRock, Inc.’s predecessor entities (since 1988); Trustee, University of Pennsylvania (since 2009); President of Board of Directors, Hope & Heroes Children’s Cancer Fund (since 2002).    Director of BlackRock, Inc. (since 2006); Director of iShares, Inc. (since 2009); Trustee of iShares Trust (since 2009).
Salim Ramji(b) (50)    Trustee
(since 2019).
   Senior Managing Director, BlackRock, Inc. (since 2014); Global Head of BlackRock’s ETF and Index Investments Business (since 2019); Head of BlackRock’s U.S. Wealth Advisory Business (2015-2019); Global Head of Corporate Strategy, BlackRock, Inc. (2014-2015); Senior Partner, McKinsey & Company (2010-2014).    Director of iShares, Inc. (since 2019); Trustee of iShares Trust (since 2019).

(a) Robert S. Kapito is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

(b) Salim Ramji is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

 

Independent Trustees
       
Name (Age)    Position(s)    Principal Occupation(s)
During the Past 5 Years
   Other Directorships Held by Trustee
Cecilia H. Herbert (71)    Trustee
(since 2011); Independent Board Chair (since 2016).
   Chair of the Finance Committee (since 2019) and Trustee and Member of the Finance, Audit and Quality Committees of Stanford Health Care (since 2016); Trustee of WNET, New York’s public media company (since 2011) and Member of the Audit Committee (since 2018) and Investment Committee (since 2011); Chair (1994-2005) and Member (since 1992) of the Investment Committee, Archdiocese of San Francisco; Trustee of Forward Funds (14 portfolios) (2009-2018); Trustee of Salient MF Trust (4 portfolios) (2015-2018); Director (1998-2013) and President (2007-2011) of the Board of Directors, Catholic Charities CYO; Trustee (2002-2011) and Chair of the Finance and Investment Committee (2006-2010) of the Thacher School.    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005); Independent Board Chair of iShares, Inc. and iShares Trust (since 2016); Trustee of Thrivent Church Loan and Income Fund (since 2019).
Jane D. Carlin (64)    Trustee
(since 2015); Risk Committee Chair (since 2016).
   Consultant (since 2012); Member of the Audit Committee (2012-2018), Chair of the Nominating and Governance Committee (2017-2018) and Director of PHH Corporation (mortgage solutions) (2012-2018); Managing Director and Global Head of Financial Holding Company Governance & Assurance and the Global Head of Operational Risk Management of Morgan Stanley (2006-2012).    Director of iShares, Inc. (since 2015); Trustee of iShares Trust (since 2015); Member of the Audit Committee (since 2016) and Director of The Hanover Insurance Group, Inc. (since (2016).
Richard L. Fagnani (65)    Trustee
(since 2017); Audit Committee Chair (since 2019).
   Partner, KPMG LLP (2002-2016).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).

 

 

74  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Trustee and Officer Information  (continued)

 

Independent Trustees (continued)
       
Name (Age)    Position(s)    Principal Occupation(s)
During the Past 5 Years
   Other Directorships Held by Trustee
John E. Kerrigan (65)    Trustee
(since 2011); Nominating and Governance and Equity Plus Committee Chairs (since 2019).
   Chief Investment Officer, Santa Clara University (since 2002).    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005).
Drew E. Lawton (61)    Trustee
(since 2017); 15(c) Committee Chair (since 2017).
   Senior Managing Director of New York Life Insurance Company (2010-2015).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).
John E. Martinez (59)    Trustee
(since 2011); Securities Lending Committee Chair (since 2019).
   Director of Real Estate Equity Exchange, Inc. (since 2005); Director of Cloudera Foundation (since 2017); and Director of Reading Partners (2012-2016).    Director of iShares, Inc. (since 2003); Trustee of iShares Trust (since 2003).
Madhav V. Rajan (55)    Trustee
(since 2011); Fixed Income Plus Committee Chair (since 2019).
   Dean, and George Pratt Shultz Professor of Accounting, University of Chicago Booth School of Business (since 2017); Robert K. Jaedicke Professor of Accounting, Stanford University Graduate School of Business (2001-2017); Professor of Law (by courtesy), Stanford Law School (2005-2017); Senior Associate Dean for Academic Affairs and Head of MBA Program, Stanford University Graduate School of Business (2010-2016).    Director of iShares, Inc. (since 2011); Trustee of iShares Trust (since 2011).

 

Officers
     
Name (Age)    Position(s)    Principal Occupation(s) During the Past 5 Years
Armando Senra (49)    President
(since 2019).
   Managing Director, BlackRock, Inc. (since 2007); Head of U.S., Canada and Latam iShares, BlackRock, Inc. (since 2019); Head of Latin America Region, BlackRock, Inc. (2006-2019); Managing Director, Bank of America Merrill Lynch (1994-2006).
Trent Walker (46)    Treasurer and Chief Financial Officer
(since 2020).
   Managing Director, BlackRock, Inc. (since September 2019); Executive Vice President of PIMCO (2016-2019); Senior Vice President of PIMCO (2008-2015); Treasurer (2013-2019) and Assistant Treasurer (2007-2017) of PIMCO Funds, PIMCO Variable Insurance Trust, PIMCO ETF Trust, PIMCO Equity Series, PIMCO Equity Series VIT, PIMCO Managed Accounts Trust, 2 PIMCO-sponsored interval funds and 21 PIMCO-sponsored closed-end funds.
Charles Park (52)    Chief Compliance Officer
(since 2011).
   Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex (since 2014); Chief Compliance Officer of BFA (since 2006).
Deepa Damre (45)    Secretary
(since 2019).
   Managing Director, BlackRock, Inc. (since 2014); Director, BlackRock, Inc. (2009-2013).
Scott Radell (51)    Executive Vice President
(since 2012).
   Managing Director, BlackRock, Inc. (since 2009); Head of Portfolio Solutions, BlackRock, Inc. (since 2009).
Alan Mason (59)    Executive Vice President
(since 2016).
   Managing Director, BlackRock, Inc. (since 2009).
Marybeth Leithead (57)    Executive Vice President
(since 2019).
   Managing Director, BlackRock, Inc. (since 2017); Chief Operating Officer of Americas iShares (since 2017); Portfolio Manager, Municipal Institutional & Wealth Management (2009-2016).

 

 

TRUSTEE AND OFFICER INFORMATION

  75


General Information

 

Electronic Delivery

Shareholders can sign up for email notifications announcing that the shareholder report or prospectus has been posted on the iShares website at iShares.com. Once you have enrolled, you will no longer receive prospectuses and shareholder reports in the mail.

To enroll in electronic delivery:

 

   

Go to icsdelivery.com.

 

   

If your brokerage firm is not listed, electronic delivery may not be available. Please contact your broker-dealer or financial advisor.

Householding

Householding is an option available to certain fund investors. Householding is a method of delivery, based on the preference of the individual investor, in which a single copy of certain shareholder documents can be delivered to investors who share the same address, even if their accounts are registered under different names. Please contact your broker-dealer if you are interested in enrolling in householding and receiving a single copy of prospectuses and other shareholder documents, or if you are currently enrolled in householding and wish to change your householding status.

Availability of Quarterly Schedule of Investments

The iShares Funds file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT, and for reporting periods ended prior to March 31, 2019, filed such information on Form N-Q. The iShares Funds’ Forms N-Q are available on the SEC’s website at sec.gov. The iShares Funds also disclose their complete schedule of portfolio holdings on a daily basis on the iShares website at iShares.com.

Availability of Proxy Voting Policies and Proxy Voting Records

A description of the policies and procedures that the iShares Funds use to determine how to vote proxies relating to portfolio securities and information about how the iShares Funds voted proxies relating to portfolio securities during the most recent twelve-month period ending June 30 is available without charge, upon request (1) by calling toll-free 1-800-474-2737; (2) on the iShares website at iShares.com; and (3) on the SEC website at sec.gov.

 

 

76  

2020 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Glossary of Terms Used in this Report

 

Portfolio Abbreviations — Equity
NVS    Non-Voting Shares
 

 

 

GLOSSARY OF TERMS USED IN THIS REPORT

  77


 

Want to know more?

iShares.com    |     1-800-474-2737

This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by the current prospectus.

Investing involves risk, including possible loss of principal.

The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).

©2020 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc. or its subsidiaries. All other marks are the property of their respective owners.

iS-AR-715-0720

 

 

LOGO    LOGO


Item 2.    Code of Ethics.

The registrant has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to clarify an inconsistency in to whom persons covered by the code should report suspected violations of the code. The amendment clarifies that such reporting should be made to BlackRock’s General Counsel, and retains the alternative option of anonymous reporting following “whistleblower” policies. Other non-material changes were also made in connection with this amendment. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon request, without charge, by calling 1-800-474-2737.

Item 3.    Audit Committee Financial Expert.

The registrant’s Board of Trustees has determined that the registrant has more than one audit committee financial expert, as that term is defined under Item 3(b) and 3(c), serving on its audit committee. The audit committee financial experts serving on the registrant’s audit committee are Richard L. Fagnani, John E. Kerrigan, and Madhav V. Rajan, all of whom are independent, as that term is defined under Item 3(a)(2).


Item 4.    Principal Accountant Fees and Services.

The principal accountant fees disclosed in items 4(a), 4(b), 4(c), 4(d) and 4(g) are for the seven series of the registrant for which the fiscal year-end is July 31, 2020 (the “Funds”), and whose annual financial statements are reported in Item 1.

 

  (a)

Audit Fees – The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the Funds’ annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years were $88,900 for the fiscal year ended July 31, 2019 and $88,900 for the fiscal year ended July 31, 2020.

 

  (b)

Audit-Related Fees – There were no fees billed for the fiscal years ended July 31, 2019 and July 31, 2020 for assurance and related services by the principal accountant that were reasonably related to the performance of the audit of the Fund’s financial statements and are not reported under (a) of this Item.

 

  (c)

Tax Fees – The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice and tax planning for the Funds were $26,467 for the fiscal year ended July 31, 2019 and $26,467 for the fiscal year ended July 31, 2020. These services related to the review of the Funds’ tax returns and excise tax calculations.

 

  (d)

All Other Fees – There were no other fees billed in each of the fiscal years ended July 31, 2019 and July 31, 2020 for products and services provided by the principal accountant, other than the services reported in (a) through (c) of this Item.

 

  (e)

(1) The registrant’s audit committee charter, as amended, provides that the audit committee is responsible for the approval, prior to appointment, of the engagement of the principal accountant to annually audit and provide their opinion on the registrant’s financial statements. The audit committee must also approve, prior to appointment, the engagement of the principal accountant to provide non-audit services to the registrant or to any entity controlling, controlled by or under common control with the registrant’s investment adviser (“Adviser Affiliate”) that provides ongoing services to the registrant, if the engagement relates directly to the operations and financial reporting of the registrant.

 

   

(2) There were no services described in (b) through (d) above that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 

  (f)

None of the hours expended on the principal accountant’s engagement to audit the Funds’ financial statements for the fiscal year ended July 31, 2020 were attributable to work performed by persons other than the principal accountant’s full-time, permanent employees.

 

  (g)

The aggregate non-audit fees billed by the registrant’s principal accountant for services rendered to the Funds, and rendered to the registrant’s investment adviser, and any Adviser Affiliate that provides ongoing services to the registrant for the last two fiscal years were $26,467 for the fiscal year ended July 31, 2019 and $26,467 for the fiscal year ended July 31, 2020.

 

  (h)

The registrant’s audit committee has considered whether the provision of non-audit services rendered to the registrant’s investment adviser and any Adviser Affiliate that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X, if any, is compatible with maintaining the principal accountant’s independence, and has determined that the provision of these services, if any, does not compromise the principal accountant’s independence.

Item 5.    Audit Committee of Listed Registrants

(a) The registrant is a listed issuer as defined in Rule 10A-3 under the Exchange Act of 1934 and has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act of 1934. The registrant’s audit committee members are Richard L. Fagnani, John E. Kerrigan, and Madhav V. Rajan.

(b) Not applicable.


Item 6.    Investments.

(a) Schedules of investments are included as part of the reports to shareholders filed under Item 1 of this Form.

(b) Not applicable.

Item 7.    Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to the registrant.

Item 8.    Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to the registrant.

Item 9.    Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to the registrant.

Item 10.   Submission of Matters to a Vote of Security Holders.

There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s Board of Trustees.

Item 11.   Controls and Procedures.

(a) The President (the registrant’s Principal Executive Officer) and Treasurer and Chief Financial Officer (the registrant’s Principal Financial Officer) have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) are effective as of a date within 90 days of the filing date of this report, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the Investment Company Act of 1940 and Rules 13a-15(b) or 15d-15(b) under the Exchange Act of 1934.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.   Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable to the registrant.

 

Item 13.

  Exhibits.

(a) (1) Code of Ethics is not filed as an exhibit; please refer to Item 2.

(a) (2) Section 302 Certifications are attached.

(a) (3) Not applicable.

(a) (4) Not applicable.

(b) Section 906 Certifications are attached.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  iShares U.S. ETF Trust  
  By: /s/ Armando Senra  
  Armando Senra, President (Principal Executive Officer)  

 

  Date:         October 5, 2020

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

  By: /s/ Armando Senra                                                             

  Armando Senra, President (Principal Executive Officer)

  Date:         October 5, 2020

  By: /s/ Trent Walker                                                                                              

  Trent Walker, Treasurer and Chief Financial Officer (Principal Financial Officer)

  Date:         October 5, 2020